nezam h afdhal  dollars for docs  propublica propublica see more atvital signs dollars for docs how industry dollars reach your doctors has your doctor received drug or device company money all statesalabama alaska american samoa arizona arkansas armed forces americas armed forces europe armed forces pacific california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern mariana islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virginia virgin islands washington west virginia wisconsin wyoming for example andrew jones boston  dollars for docs » massachusetts » nezam h afdhal is this your doctor print out this record along with questions and tips for talking with your physician about payments have you used or plan to use this information tell us about it nezam h afdhal listed specialty hepatology bidmc  francis st ste e boston ma  search this name in dollars for docs archive » is this you do you believe the data contains errors click here for information » is this your doctor print out this record along with questions and tips for talking with your physician about payments have you used or plan to use this information tell us about it nezam afdhal yearly payment breakdown    all payments at a glance   payments  payment total  companies paid this doctor   payments  payment total  companies paid this doctor   payments  payment total  companies paid this doctor payment calendar in this doctor received a payment on days in  each box below represents a single day during the disclosure period a gray box indicates no payments the darker the color the more payments a doctor received that day types of payments in category payments payment value consulting  k consulting   honoraria   consulting   travel and lodging   travel and lodging   promotional speakingother   travel and lodging   honoraria   promotional speakingother   food and beverage   food and beverage   food and beverage   gift   drugs  devices in totals listed below account for all payments from august  to december  that mention this product if a payment record mentions more than one product the entire value will be included in each of those products this physician does not have any payments relating to a specific drug or device for this year product name product type payments† synthroid drug  lupron drug  viekira drug  androgel drug  humira drug  other drug  daklinza drug  † may not add up to dollar total at top of page since a payment record may not be associated with any product or can be associated with several products product name product type payments† other drug  sovaldi drug  olysio drug  victrelis drug  baraclude drug  † may not add up to dollar total at top of page since a payment record may not be associated with any product or can be associated with several products product name product type payments† revolade drug  promacta drug  rebozet drug  other drug  pegintron drug  invanz drug  victrelis drug  cancidas drug  isentress drug  hepsera drug  viread drug  incivek drug  baraclude drug  † may not add up to dollar total at top of page since a payment record may not be associated with any product or can be associated with several products payment details in when how much related to what for from third party payee aug    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc mar    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc mar    no listed product honoraria additional details on this payment » intlehurryehurryvpl gilead sciences inc may    other consulting merck sharp  dohme corporation aug    revolade rebozet promacta consulting glaxosmithkline llc aug    promacta revolade rebozet travel and lodging glaxosmithkline llc dec    no listed product honoraria additional details on this payment » healthagaboragaborvpl gilead sciences inc may    humira viekira synthroid androgel lupron consulting abbvie inc apr    no listed product consulting abbvie inc dec    no listed product consulting abbvie inc may    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc aug    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc oct    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc dec    humira viekira synthroid androgel lupron consulting abbvie inc sep    no listed product travel and lodging additional details on this payment » ehurryehurrygilead sciencesvrl gilead sciences inc mar    other consulting merck sharp  dohme corporation feb    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc oct    other travel and lodging merck sharp  dohme corporation may    olysio consulting janssen global services llc jun    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc dec    no listed product consulting er squibb  sons llc aug    sovaldi consulting gilead sciences inc trio health ssc apr    no listed product honoraria additional details on this payment » commindvpl gilead sciences inc oct    no listed product honoraria additional details on this payment » gilead sciencesvrl ldgab honoraria payment sept  paris france gilead sciences inc oct    other promotional speakingother merck sharp  dohme corporation mar    no listed product travel and lodging additional details on this payment » intlehurryehurryvpl gilead sciences inc aug    no listed product consulting additional details on this payment » clinindvpl gilead sciences inc feb    no listed product consulting boehringer ingelheim pharmaceuticals inc nov    other consulting merck sharp  dohme corporation jun    sovaldi consulting gilead sciences inc trio health ssc jan    no listed product honoraria additional details on this payment » intlehurryehurryvpl gilead sciences inc dec    no listed product consulting abbvie inc may    no listed product consulting er squibb  sons llc oct    isentress pegintron cancidas victrelis invanz travel and lodging additional details on this payment » this activity was conducted at the therapy area level not productspecific the products reported are the merck marketed products in the therapy area and they may or may not have been discussed as a part of this event for purposes of reporting we will report both the therapy area and product but we will only report ndcs at the product level merck sharp  dohme corporation aug    other consulting additional details on this payment » provided as part of a consulting engagement merck sharp  dohme corporation mar    other consulting merck sharp  dohme corporation mar    other consulting merck sharp  dohme corporation dec    no listed product consulting er squibb  sons llc nov    no listed product consulting er squibb  sons llc jun    no listed product honoraria additional details on this payment » intlehurryehurryvpl gilead sciences inc jun    victrelis promotional speakingother merck sharp  dohme corporation apr    no listed product travel and lodging abbvie inc mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation mar    other promotional speakingother merck sharp  dohme corporation feb    other travel and lodging merck sharp  dohme corporation mar    no listed product travel and lodging additional details on this payment » clinindvpl gilead sciences inc jan    no listed product consulting er squibb  sons llc aug    no listed product travel and lodging additional details on this payment » clinindvpl gilead sciences inc jul    no listed product travel and lodging additional details on this payment » cadmehurryehurryvpl gilead sciences inc mar    no listed product travel and lodging additional details on this payment » intlehurryehurryvpl gilead sciences inc jul    no listed product travel and lodging additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc aug    no listed product travel and lodging additional details on this payment » gilead sciencesvrl gilead sciences inc mar    no listed product travel and lodging additional details on this payment » intlehurryehurryvpl gilead sciences inc nov    no listed product travel and lodging er squibb  sons llc aug    revolade rebozet promacta travel and lodging glaxosmithkline llc dec    no listed product consulting er squibb  sons llc dec    no listed product travel and lodging boehringer ingelheim pharmaceuticals inc apr    no listed product travel and lodging abbvie inc may    no listed product travel and lodging er squibb  sons llc aug    no listed product travel and lodging additional details on this payment » healthagaboragaborvpl gilead sciences inc may    humira viekira synthroid androgel lupron travel and lodging abbvie inc aug    hepsera travel and lodging additional details on this payment » jjablonskijjablonskigilead sciences gilead sciences inc dec    no listed product travel and lodging abbvie inc jun    victrelis travel and lodging merck sharp  dohme corporation nov    no listed product travel and lodging er squibb  sons llc nov    no listed product travel and lodging er squibb  sons llc sep    no listed product travel and lodging additional details on this payment » aweinsteinaweinsteingilead sciencesvrl gilead sciences inc feb    other travel and lodging merck sharp  dohme corporation feb    other travel and lodging merck sharp  dohme corporation jul    victrelis travel and lodging merck sharp  dohme corporation dec    no listed product consulting vertex pharmaceuticals incorporated feb    other travel and lodging merck sharp  dohme corporation may    other travel and lodging merck sharp  dohme corporation oct    isentress pegintron cancidas victrelis invanz travel and lodging additional details on this payment » this activity was conducted at the therapy area level not productspecific the products reported are the merck marketed products in the therapy area and they may or may not have been discussed as a part of this event for purposes of reporting we will report both the therapy area and product but we will only report ndcs at the product level merck sharp  dohme corporation oct    isentress pegintron cancidas victrelis invanz travel and lodging additional details on this payment » this activity was conducted at the therapy area level not productspecific the products reported are the merck marketed products in the therapy area and they may or may not have been discussed as a part of this event for purposes of reporting we will report both the therapy area and product but we will only report ndcs at the product level merck sharp  dohme corporation may    other food and beverage merck sharp  dohme corporation mar    other travel and lodging merck sharp  dohme corporation nov    no listed product travel and lodging er squibb  sons llc oct    viread food and beverage additional details on this payment » mrichardsonmrichardsongilead sciences gilead sciences inc may    other travel and lodging merck sharp  dohme corporation oct    other travel and lodging merck sharp  dohme corporation may    other travel and lodging merck sharp  dohme corporation mar    other travel and lodging merck sharp  dohme corporation mar    other travel and lodging merck sharp  dohme corporation nov    other travel and lodging merck sharp  dohme corporation jun    victrelis travel and lodging merck sharp  dohme corporation jun    victrelis travel and lodging merck sharp  dohme corporation jun    victrelis travel and lodging merck sharp  dohme corporation feb    other travel and lodging merck sharp  dohme corporation feb    other travel and lodging merck sharp  dohme corporation nov    no listed product food and beverage additional details on this payment » aweinsteinaweinsteingilead sciencesvrl gilead sciences inc nov    no listed product food and beverage additional details on this payment » jjablonskijjablonskigilead sciences gilead sciences inc dec    no listed product travel and lodging boehringer ingelheim pharmaceuticals inc nov    no listed product food and beverage additional details on this payment » healthagaboragaborvpl gilead sciences inc mar    no listed product food and beverage additional details on this payment » intlehurryehurryvpl gilead sciences inc jul    no listed product food and beverage additional details on this payment » cadmehurryehurryvpl gilead sciences inc mar    no listed product food and beverage additional details on this payment » intlehurryehurryvpl gilead sciences inc aug    hepsera food and beverage additional details on this payment » jjablonskijjablonskigilead sciences gilead sciences inc jul    no listed product food and beverage additional details on this payment » cadmehurryehurryvpl gilead sciences inc jun    victrelis food and beverage merck sharp  dohme corporation feb    other food and beverage merck sharp  dohme corporation may    no listed product food and beverage er squibb  sons llc oct    other travel and lodging merck sharp  dohme corporation nov    humira viekira synthroid androgel lupron travel and lodging abbvie inc nov    humira viekira synthroid androgel lupron travel and lodging abbvie inc nov    humira viekira synthroid androgel lupron travel and lodging abbvie inc nov    humira viekira synthroid androgel lupron travel and lodging abbvie inc mar    no listed product food and beverage er squibb  sons llc nov    no listed product travel and lodging er squibb  sons llc jul    no listed product food and beverage additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc jul    no listed product gift additional details on this payment » tcarritherssab jacket gilead sciences inc jul    no listed product food and beverage additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc may    olysio food and beverage janssen global services llc nov    no listed product food and beverage er squibb  sons llc feb    other food and beverage merck sharp  dohme corporation nov    no listed product food and beverage er squibb  sons llc mar    other food and beverage merck sharp  dohme corporation aug    no listed product food and beverage additional details on this payment » healthagaboragaborvpl gilead sciences inc mar    no listed product consulting glaxosmithkline llc dec    no listed product food and beverage boehringer ingelheim pharmaceuticals inc sep    no listed product food and beverage additional details on this payment » aweinsteinaweinsteingilead sciencesvrl gilead sciences inc feb    other travel and lodging merck sharp  dohme corporation feb    other travel and lodging merck sharp  dohme corporation nov    no listed product food and beverage er squibb  sons llc nov    no listed product food and beverage er squibb  sons llc feb    other food and beverage merck sharp  dohme corporation feb    other food and beverage merck sharp  dohme corporation feb    other food and beverage merck sharp  dohme corporation dec    no listed product food and beverage boehringer ingelheim pharmaceuticals inc oct    isentress pegintron cancidas victrelis invanz food and beverage additional details on this payment » this activity was conducted at the therapy area level not productspecific the products reported are the merck marketed products in the therapy area and they may or may not have been discussed as a part of this event for purposes of reporting we will report both the therapy area and product but we will only report ndcs at the product level merck sharp  dohme corporation oct    isentress pegintron cancidas victrelis invanz food and beverage additional details on this payment » this activity was conducted at the therapy area level not productspecific the products reported are the merck marketed products in the therapy area and they may or may not have been discussed as a part of this event for purposes of reporting we will report both the therapy area and product but we will only report ndcs at the product level merck sharp  dohme corporation feb    other food and beverage merck sharp  dohme corporation jul    no listed product food and beverage additional details on this payment » cadmehurryehurryvpl gilead sciences inc jul    no listed product food and beverage additional details on this payment » cadmehurryehurryvpl gilead sciences inc nov    no listed product food and beverage er squibb  sons llc jul    no listed product food and beverage additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc nov    no listed product food and beverage abbvie inc mar    other food and beverage merck sharp  dohme corporation feb    other food and beverage merck sharp  dohme corporation aug    no listed product travel and lodging additional details on this payment » healthagaboragaborvpl gilead sciences inc sep    no listed product food and beverage additional details on this payment » aweinsteinaweinsteingilead sciencesvrl gilead sciences inc nov    no listed product food and beverage er squibb  sons llc nov    no listed product food and beverage er squibb  sons llc jul    no listed product travel and lodging additional details on this payment » cadmehurryehurryvpl gilead sciences inc jul    no listed product travel and lodging additional details on this payment » cadmehurryehurryvpl gilead sciences inc dec    no listed product food and beverage boehringer ingelheim pharmaceuticals inc nov    no listed product food and beverage additional details on this payment » healthagaboragaborvpl gilead sciences inc mar    no listed product food and beverage additional details on this payment » intlehurryehurryvpl gilead sciences inc mar    no listed product food and beverage additional details on this payment » intlehurryehurryvpl gilead sciences inc mar    other food and beverage merck sharp  dohme corporation sep    baraclude food and beverage er squibb  sons llc jul    no listed product food and beverage additional details on this payment » cadmehurryehurryvpl gilead sciences inc may    baraclude food and beverage er squibb  sons llc aug    no listed product food and beverage additional details on this payment » healthagaboragaborvpl gilead sciences inc jul    no listed product travel and lodging additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc jul    no listed product travel and lodging additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc nov    no listed product food and beverage er squibb  sons llc jul    no listed product food and beverage additional details on this payment » cadmehurryehurryvpl gilead sciences inc nov    humira viekira synthroid androgel lupron food and beverage abbvie inc may    no listed product food and beverage er squibb  sons llc nov    no listed product food and beverage abbvie inc nov    humira viekira synthroid androgel lupron food and beverage abbvie inc jul    no listed product food and beverage additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc nov    humira viekira synthroid androgel lupron food and beverage abbvie inc nov    no listed product food and beverage abbvie inc nov    humira viekira synthroid androgel lupron food and beverage abbvie inc may    no listed product food and beverage er squibb  sons llc jul    no listed product food and beverage additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc nov    no listed product food and beverage abbvie inc nov    no listed product food and beverage abbvie inc apr    humira viekira synthroid androgel lupron food and beverage abbvie inc apr    no listed product food and beverage abbvie inc nov    humira viekira synthroid androgel lupron food and beverage abbvie inc jul    baraclude food and beverage er squibb  sons llc jul    no listed product food and beverage additional details on this payment » tcarritherstcarrithersgilead sciencesvrl gilead sciences inc may    no listed product travel and lodging er squibb  sons llc nov    no listed product food and beverage er squibb  sons llc apr    humira viekira synthroid androgel lupron food and beverage abbvie inc aug    incivek food and beverage vertex pharmaceuticals incorporated nov    no listed product food and beverage er squibb  sons llc sep    incivek food and beverage vertex pharmaceuticals incorporated mar    no listed product food and beverage additional details on this payment » intlehurryehurryvpl gilead sciences inc sep    daklinza food and beverage er squibb  sons llc nov    no listed product travel and lodging er squibb  sons llc dec    no listed product food and beverage boehringer ingelheim pharmaceuticals inc nov    no listed product food and beverage er squibb  sons llc oct    baraclude food and beverage er squibb  sons llc nov    no listed product food and beverage er squibb  sons llc nov    no listed product food and beverage er squibb  sons llc oct    incivek food and beverage vertex pharmaceuticals incorporated aug    incivek food and beverage vertex pharmaceuticals incorporated apr    no listed product food and beverage abbvie inc apr    no listed product food and beverage abbvie inc apr    humira viekira synthroid androgel lupron food and beverage abbvie inc apr    no listed product food and beverage abbvie inc nov    no listed product food and beverage er squibb  sons llc nov    humira viekira synthroid androgel lupron food and beverage abbvie inc apr    no listed product food and beverage abbvie inc jul    baraclude food and beverage er squibb  sons llc apr    no listed product food and beverage abbvie inc mar    no listed product food and beverage er squibb  sons llc nov    no listed product food and beverage abbvie inc nov    no listed product food and beverage abbvie inc may    baraclude food and beverage er squibb  sons llc may    baraclude food and beverage er squibb  sons llc apr    humira viekira synthroid androgel lupron food and beverage abbvie inc apr    humira viekira synthroid androgel lupron food and beverage abbvie inc may    no listed product food and beverage er squibb  sons llc aug    baraclude food and beverage er squibb  sons llc apr    no listed product travel and lodging abbvie inc sep    incivek food and beverage vertex pharmaceuticals incorporated sep    daklinza food and beverage er squibb  sons llc dec    no listed product food and beverage abbvie inc nov    no listed product food and beverage er squibb  sons llc apr    no listed product food and beverage abbvie inc aug    no listed product food and beverage additional details on this payment » concurvpl gilead sciences inc oct    no listed product food and beverage additional details on this payment » concurvpl gilead sciences inc see this doctor’s open payments page » note we have made some effort to normalize the data and eliminate duplicates but data is primarily as it has been reported by the companies to the centers for medicare and medicaid services to purchase the normalized data please visit the propublica data store if you spot an error please let us know at drugspropublicaorg propublica  copyright pro publica inc dr nezam afdhal gastroenterology  boston  ma  sharecare ask a health related question join sharecare log in find a doctor health experts topics video health tools profile locations more find a doctor  gastroenterology  ma  boston  dr nezam afdhal md dr nezam afdhal gastroenterology  internal medicine boston ma male  years of experience  insurance plans languages supported at his practice german vietnamese spanish french english italian accepting new patients electronic health records dr afdhals background bio nezam h afdhal md is a practicing gastroenterologist in boston ma dr afdhal graduated from royal college of surgeons in ireland in  and has been in practice for  years dr afdhal also specializes in internal medicine and hepatology he currently practices at beth israel deaconess medical center hemostasis  thrombosis program and is affiliated with beth israel deaconess medical center boston childrens hospital and boston medical center dr afdhal accepts multiple insurance plans including aetna harvard pilgrim and tufts health plan dr afdhal is board certified in internal medicine in addition to english dr afdhals practice supports these languages german vietnamese spanish french and italian specialties gastroenterology internal medicine hepatology hospital affiliations beth israel deaconess medical center boston childrens hospital boston medical center education medical school  royal college of surgeons in ireland learn more about gastroenterology article see all articles  what your poo says about you bowel movements are not exactly dinner party conversation you may even be too embarrassed to talk about them with your doctor that’s a mistake though a change in your poop’s color might be something read more questions see all questions  how should i prepare for an appointment to diagnose fecal incontinence when should i call my doctor if i have diarrhea primary location  francis st boston ma  see all locations phone number have you visited dr afdhal before yes no   similar doctors dr thomas kelleher gastroenterology  francis st boston ma  dr daryl lau gastroenterology  francis st boston ma  dr harry anastopoulos gastroenterology  francis st boston ma  dr susan kelly gastroenterology  francis st boston ma  dr michael apstein gastroenterology  francis st boston ma   npi number — nezam h afdhal md tweet change text size   sign in   documentation   contact us lookups soaprest api medicare payerseins crosswalks  claim form library validation all services medical data services healthcare lookup services npi lookup  npi  nezam h afdhal md npi number  general information png   text   pdf   xml    json npi number  similar providers entity type code individual provider name  organization nezam h afdhal md provider business mailing address copy mailing address first line  francis st ste e  second line   city boston  state ma  postal code zip   country us  phone   fax   provider business practice location copy practice location first line bidmc  second line  francis st ste e  city boston  state ma  postal code zip   country us  phone   fax   authorized official title or position   name   credential   telephone number   provider enumeration date   last updated   is this your account edit delete synchronize detailed information npi number  has the individual type of ownership and has been registered to the following primary business legal name which is a provider name or healthcare organization name — nezam h afdhal md records indicate that the provider gender is male the enumeration date of this npi number is  npi number information was last updated on  the provider is physically located business practice location at bidmc  francis st ste e boston ma  us nezam h afdhal md can be reached at his practice location using the following numbers phone  fax the providers official mailing address is  francis st ste e boston ma  us the contact numbers associated with the mailing address are phone  fax scope of practice the following information about the specialty of the provider is available  taxonomy code taxonomy specialty license number license state  rix hepatology  ma legacy other identifiers for crosswalk purposes the following legacy nonnpi identifiers are available for this provider  provider identifier identifier type identifier state issuer reference npi information full replica of the cms nppes npi record field name value description npi  position allnumeric identification number assigned by the nps to uniquely identify a health care provider entity type individual code describing the type of health care provider that is being assigned an npi codes are   person individual human being who furnishes health care   nonperson entity other than an individual human being that furnishes health care for example hospital snf hospital subunit pharmacy or hmo is sole proprietor n indicate whether provider is a sole proprietor a sole proprietor is the sole the only owner of a business that is not incorporated that unincorporated business is a sole proprietorship in a sole proprietorship the sole proprietor owns all of the assets of the business and is solely liable for all of the debts of the business there is no difference between a sole proprietorship and a sole proprietor they are legally a single entity an individual in terms of npi assignment a sole proprietor is an entity type  individual and is eligible for only one npi the sole proprietorship business is not eligible for its own npi as an individual a sole proprietorship cannot be a subpart and cannot have subparts see npi final rule for information about subparts a sole proprietorship may or may not have employees often the irs assigns an ein to a sole proprietorship in order to protect the sole proprietors ssn from disclosure in claims or on ws nppes does not capture a sole proprietorships ein many types of health care providers could be sole proprietorships for example group practices pharmacies home health agencies provider last name legal name afdhal the last name of the provider if an individual if the provider is an individual this is the legal name this name must match the name on file with the social security administration ssa in addition the date of birth must match that on file with ssa first and last names are required for initial applications the first middle last and credentials fields allow the following special characters ampersand apostrophe colon comma forward slash hyphen left and right parentheses period pound sign quotation mark and semicolon a field cannot contain all special characters provider first name nezam the first name of the provider if the provider is an individual provider middle name h the middle name of the provider if the provider is an individual provider credential text md the abbreviations for professional degrees or credentials used or held by the provider if the provider is an individual examples are md dds csw cna aa np rna or psy these credential designations will not be verified by nps provider first line business mailing address  francis st ste e the first line mailing address of the provider being identified this data element may contain the same information as provider first line location address provider business mailing address city name boston the city name in the mailing address of the provider being identified this data element may contain the same information as provider location address city name provider business mailing address state name ma the state or province name in the mailing address of the provider being identified this data element may contain the same information as provider location address state name provider business mailing address postal code  the postal zip or zone code in the mailing address of the provider being identified note zip code plus digit extension if available this data element may contain the same information as provider location address postal code provider business mailing address country code us the country code in the mailing address of the provider being identified this data element may contain the same information as provider location address country code provider business mailing address telephone number  the telephone number associated with mailing address of the provider being identified this data element may contain the same information as provider location address telephone number provider first line business practice location address bidmc the first line location address of the provider being identified for providers with more than one physical location this is the primary location this address cannot include a post office box provider second line business practice location address  francis st ste e the second line location address of the provider being identified for providers with more than one physical location this is the primary location this address cannot include a post office box provider business practice location address city name boston the city name in the location address of the provider being identified provider business practice location address state name ma the state or province name in the location address of the provider being identified provider business practice location address postal code  the postal zip or zone code in the location address of the provider being identified note zip code plus digit extension if available provider business practice location address country code us the country code in the location address of the provider being identified provider business practice location address telephone number  the telephone number associated with the location address of the provider being identified provider enumeration date  the date the provider was assigned a unique identifier assigned an npi last update date  the date that a record was last updated or changed provider gender code m the code designating the providers gender if the provider is a person provider gender male the providers gender if the provider is a person healthcare provider taxonomy code  rix the health care provider taxonomy code is a unique alphanumeric code ten characters in length the code set is structured into three distinct levels including provider type classification and area of specialization healthcare provider taxonomy  hepatology healthcare provider taxonomy  provider license number   certain taxonomy selections will require you to enter your license number and the state where the license was issued select foreign country in the state drop down box if the license was issued outside of united states the license number field allows the following special characters ampersand apostrophe colon comma forward slash hyphen left and right parentheses period pound sign quotation mark and semicolon a field cannot contain all special characters do not report the social security number ssn irs individual taxpayer identification number itin in this section provider license number state code  ma provider license number state code  healthcare provider primary taxonomy switch  y primary taxonomy x  the primary taxonomy switch is not answered y  the taxonomy is the primary taxonomy there can be only one per npi record n  the taxonomy is not the primary taxonomy driving directions to  nezam h afdhal md practice location these directions are for planning purposes only you may find that construction projects traffic or other events may cause road conditions to differ from the map results yours location starting point practice location destination join faq sign up about us contact us terms of use privacy policy our customers site map products  apis buy medical data cloud restsoap api  claim form to edi crosswalk services validation services npi registry trends documentation api information npi service faq rest api test drive medical coding trainer medical coding library medical coding library npi registry hcpcs directory national drug codes icdcm codes icdcm codes icd drugs  chemicals loinc codes directory msdrgs animal drug products naics code directory medical devices gudid ein directory cms forms validation services all validation services hipaaedi validation npi validation upin validation ein validation itin validation clia validation duns validation duns validation dea validation tns validation hin validation upc code validation nhric code validation lookup services npi number lookup hcpcs codes lookup ndc number lookup icd codes lookup icd codes lookup icd drugs substance lookup clia codes lookup naics codes lookup loinc codes lookup drg lookup taxonomy codes lookup animal drug products lookup global medical devices lookup pqrs quality measures lookup rxnorm concept id lookup copyright   powered by swiss vault engine all rights reserved hipaa liability trademark document use and software licensing rules apply all registered trademarks used in the content are the property of their owners your interactions with this site are in accordance with our terms of use and privacy policy the loinc table loinc codes and loinc panels and forms file are copyright   regenstrief institute inc nezam h afdhal md  celiac disease foundation menu celiac disease foundation you are here home › celiac disease › resources › find a healthcare practitioner › nezam h afdhal md nezam h afdhal md gastroenterology hepatology celiac disease center nezam h afdhal md  francis st ste e boston ma   get directions general information gender male languages spoken arabic cambodian chinese english farsi haitian portuguese spanish education school royal college of surgeons in ireland graduation date  license license number  expiration date  verification date hospital affiliations beth israel deaconess medical center the information contained in this web site is being made available as a public service by celiac disease foundation cdf no posted information or material provided is intended to constitute medical or professional advice the information contained in this web site for healthcare practitioner license and education information was supplied from state license boards cdf makes no representations or warranties either express or implied as to the accuracy of any posted information and assumes no responsibility for any errors or omissions contained therein furthermore no warranty express or implied is created by providing information through this web site and the presence of an individual healthcare practitioner on the web site does not in any way constitute an endorsement by cdf no one shall be entitled to claim detrimental reliance on any views or information whether provided by or accessed through this web site or to claim any duty on our part to update posted information or to protect the interests of those accessing this web site in no event shall cdf be held liable to you or anyone else for any decision made or action taken in reliance on such information or views for more information regarding a healthcare practitioners license please contact the state licensing board responsible for the license directly nezam afdhal spring bank pharmaceuticals inc profile  biography  bloomberg feedback nezam afdhal chief medical officer spring bank pharmaceuticals inc career history chief medical officer spring bank pharmaceuticals inc present senior physicianhepatology beth israel deaconess medical center inc present associate professormedicine harvard medical school present consultant spring bank pharmaceuticals inc  chief of hepatology beth israel deaconess medical center inc  chiefhepatology medgenics inc unknown directorliver center beth israel deaconess medical center inc former show more website wwwspringbankpharmcom corporate information address  south street hopkinton ma  united states phone  fax  web url wwwspringbankpharmcom from the web personal information education royal college of surgeons md memberships other memberships american liver foundation board member hcv board member american gastroenterological association member american association for the study of liver diseases member european association for the study of the liver member show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data nezam afdhal  harvard catalyst profiles  harvard catalyst about harvard catalyst national ctsa consortium contact us news  events spotlights people  collaboration overview people  collaboration harvard catalyst profiles contact publication and social network information about harvard faculty and fellows consulting  advice overview bioinformatics consulting advice on bioinformatics related to clinical and translational research biostatistical consulting advice on biostatistical topics related to clinical  translational research imaging facilitation connecting investigators with medical imaging experts indide consulting consultation for investigators and irbs on issues relating to indide studies population health research consulting training and technical assistance in research and evaluation methods quality assurancequality improvement qaqi consulting consultation for irbs to develop qaqi activities education  training overview courses bioinformatics workshops a workshop series on how to efficiently manage and analyze sequencing data biostatistics continuing education talks focused on translating recent advances in biostatistics into practice certificate in applied biostatistics a week online course on the principles and methods of biostatistics clinical trial design ctd week hybrid inpersononline course on the design  implementation of clinical trials comparative effectiveness research cer overview of cer methods effectively communicating research an intensive course on the fundamentals of communicating ones research fundamentals of clinical and translational research factor online course that offers an overview of clinical research and the t spectrum funding your research nih online course for researchers applying for nih grant funding health disparities research training and events training education and networking in transdisciplinary disparities research topics imaging methods for clinical and translational research introductory online course for imaging technologies introduction to omics research an online course about the scope analytical methods  challenges of omics research introduction to clinical investigation a fourday introductory course on the principles and methods of clinical investigation introduction to mixed methods research online course introducing participants to mixed methods research in the health sciences introduction to translational medicine courses on the principles  practices of translational research leadership strategies for the researcher learn the skills needed to lead and manage a research team successfully medical device development a twoday course on medical device innovation development and translation mentoring program a program that supports mentoring relationships in clinical and translational research models of disease mod boot camp threeweek course for clinical fellows starting basictranslational postdoctoral research network medicine a course series on network science in biology and medicine regulatory education and events series talks focused on regulatory issues and emerging topics in research responsible conduct of research rcr a resource for rcr education and training successful grant writing strategies sgws online course for researchers seeking and applying for grant funding tt research translating effective interventions into practice an introductory course on the tt translational research domains understanding biomarker science from molecules to images a onestopshop for translational biomarker research training programsfellowships biomedical informatics master of medical sciences a year masters training program in biomedical informatics research biostatistics training a credit hsph master of science program in applied biostatistics clinical and translational ct research academy advanced training program that offers a pathway to conducting independent research clinical research orientation program for phds cropp an eightweek program for phds interested in clinical and translational research grant review and support program a multiyear program for k grant awardees seeking independent research funding klcatalyst medical research investigator training a twoyear mentored research  education program for junior faculty and senior fellows leder human biology  translational medicine an enrichment program for phd students on the fundamentals of human biology  disease mixed methods research training program for the health sciences a yearlong mentoring training program in mixed methods educational resources advanced curriculum compendium a searchable catalog of advanced coursesseminars for translational investigators community capacity building seminar series talks focused on translating skills to public health professionals education video library a digital library of archived videos from past educational offerings irb visiting program observe and learn about the irb review process best practices and innovative methods thinkresearch podcast a podcast series highlighting fascinating stories of medical research funding overview funding opportunities football players health study pilot funding funding opportunities from the football players health study at harvard university pilot funding grants for clinical and translational research projects funding resources elements of grant writing tips and work plans for the grant writing process research resources overview tools  services core facilities a searchable database of core laboratory facilities hccrc lab services laboratory assay consulting new assay development and subsidized research tests hccrc protocol review access the resources of five harvard and mitaffiliated clinical research centers irb cede review request request single or consolidated irb review for a multisite study redcap research electronic data capture free webbased electronic data capture tools to support clinical and research studies shrine search deidentified data from clinic visits at several harvardaffiliated hospitals information  support atlas find directions phone numbers  more from harvard catalysts partner institutions countway library research services connecting investigators to bibliographic and bioinformatic tools  knowledge harvardtrials a harvard view of clinicaltrialsgov regulatory atlas a directory of institutional regulatory offices forms policies  training for research regulatory binder a template for maintaining regulatory documentation in human subjects research research subject advocacy materials videos and resources to support engagement with research participants programs overview harvard catalyst programs advanced clinical and translational research training programs three training programs that focus on didactic course work and mentored ct research biomedical informatics program bringing data populations researchers  tools together to accelerate biomedical research biostatistics program providing statistical expertise for clinical  translational investigators child health addressing clinical  translational research needs associated with child health harvard catalyst clinical research center hccrc access the resources of five harvard catalyst clinical research centers health disparities research program develop cuttingedge research to understand and eliminate health disparities pilot  collaborative translational  clinical studies program supporting novel collaborative research on critical problems in human health population health research program innovation  improvement in public health via community engagement  research postgraduate education in ct science program comprehensive opportunities for postgraduate clinical  translational education program for faculty development  diversity inclusion fostering the growth of a diverse clinical  translational workforce reactor accelerating clinical and translational research supporting innovation and teams in diagnostics prevention biomarkers and therapeutics regulatory foundations ethics and law program helping researchers navigate clinical  translational research regulatory processes related programs related programs  initiatives harvardaffiliated multidisciplinary programs centers and initiatives contact publication and social network information about harvard faculty and fellows harvard catalyst profiles keywords last name institution beth israel deaconess medical centerboston childrens hospitalbrigham and womens hospitalcambridge health alliancedanafarber cancer institutefaculty of arts  sciencesforsyth institutegraduate school of educationharvard business schoolharvard divinity schoolharvard insitutes of medicineharvard law schoolharvard medical schoolharvard pilgrim healthcareharvard school of dental medicineharvard th chan school of public healthharvard universityhebrew rehabilitation centerimmune disease institutejohn f kennedy school of governmentjoslin diabetes centerjudge baker childrens centerlahey clinic medical centermass mental health centermassachusetts eye and ear infirmarymassachusetts general hospitalmassachusetts institute of technologymclean hospitalmount auburn hospitalnew england baptist hospitalnewtonwellesley hospitalotherradcliffe institute for advanced studyschepens eye research instituteschool of engineering and applied sciencesspaulding rehabilitation hospitalveterans affairs boston healthcare system more search options menu find peoplefind everythingabout this siteedit my profileexport rdf login to profiles nezam hassan afdhal md titleprofessor of medicine parttimeinstitutionbeth israel deaconess medical centerdepartmentmedicineaddressbeth israel deaconess medical centerliver research ctr  suite a francis street boston ma phoneemailvcarddownload vcard login for email  research  research activities and funding the research activities and funding listed below are automatically derived from nih exporter and other sources which might result in incorrect or missing items faculty can login to make corrections and additions most recent    list all uat     afdhal nezam hassanaug    jul  nihnccihclinical center for phase iii trials of silymarin in chronic liver diseaserole principal investigatoruai     schuppan detlefjun    nov  nihniaiddeterminants of liver injury in chronic hepatitis c virus infectionrole coprincipal investigatorrca     afdhal nezam hassansep    aug  nihnciproteomics and biomarkers for hepatocellular cancerrole principal investigatorudk     afdhal nezam hassanaug    jun  nihniddkantiviral therapy in african americans with hcvrole principal investigatorrdk     afdhal nezam hassanjul    may  nihniddkprotein lipid interactions in gallstone pathogenesisrole principal investigatormrr     sukhatme vikas pdec    mar  nihncrrgeneral clinical research centerrole coprincipal investigator  bibliographic  selected publications publications listed below are automatically derived from medlinepubmed and other sources which might result in incorrect or missing publications faculty can login to make corrections and additions list all      timeline curry mp tapper eb bacon b dieterich d flamm sl guest l kowdley kv lee y milligan s tsai n younossi z afdhal nh effectiveness of  or weeks of ledipasvir and sofosbuvir in realworld treatmentnaïve genotype  hepatitis c infected patients aliment pharmacol ther  jul  pmid  view in pubmed jones m cunningham me wing p desilva s challa r sheri a padmanabhan s iyer rp korba be afdhal n foster gr sb  a novel agonist of innate immunity shows potent antiviral activity against resistant hcv variants j med virol  sep  pmid  view in pubmed tapper eb afdhal nh curry mp before or after transplantation a review of the cost effectiveness of treating waitlisted patients with hepatitis c transplantation  may  pmid  view in pubmed tapper eb hughes ms buti m dufour jf flamm s firdoos s curry mp afdhal nh the optimal timing of hepatitis c therapy in transplant eligible patients with child b and c cirrhosis a costeffectiveness analysis transplantation  may  pmid  view in pubmed iriana s curry mp afdhal nh neurologic manifestations of hepatitis c virus infection clin liver dis  aug  pmid  view in pubmed afdhal n everson gt calleja jl mccaughan gw bosch j brainard dm mchutchison jg deoertel s an d charlton m reddy kr asselah t gane e curry mp forns x effect of viral suppression on hepatic venous pressure gradient in hepatitis c with cirrhosis and portal hypertension j viral hepat  mar  pmid  view in pubmed jacobson im washington mk buti m thompson a afdhal n flisiak r akarca us tchernev kg flaherty jf aguilar schall r myers rp subramanian gm mchutchison jg younossi z marcellin p patel k factors associated with persistent increase in level of alanine aminotransferase in patients with chronic hepatitis b receiving oral antiviral therapy clin gastroenterol hepatol  jul e pmid  view in pubmed suresh m korolowicz ke balarezo m iyer rp padmanabhan s cleary d gimi r sheri a yon c kallakury bv tucker rd afdhal n menne s antiviral efficacy and host immune response induction during sequential treatment with sb  followed by entecavir in woodchucks plos one  e pmid  view in pubmed wyles d dvorysobol h svarovskaia es doehle bp martin r afdhal nh kowdley kv lawitz e brainard dm miller md mo h gane ej posttreatment resistance analysis of hepatitis c virus from phase ii and iii clinical trials of ledipasvirsofosbuvir j hepatol  apr  pmid  view in pubmed tapper eb bacon br curry mp dieterich dt flamm sl guest le kowdley kv lee y tsai nc younossi zm afdhal nh realworld effectiveness for  weeks of ledipasvirsofosbuvir for genotype  hepatitis c the trio health study j viral hepat  jan  pmid  view in pubmed tapper eb bacon br curry mp dieterich dt flamm sl guest le kowdley kv lee y tsai nc younossi zm afdhal nh evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a realworld cohort study hepatology  dec  pmid  view in pubmed afdhal nh serfaty l effect of registries and cohort studies on hcv treatment gastroenterology  sep  pmid  view in pubmed younossi zm stepanova m sulkowski m foster gr reau n mangia a patel k bräu n roberts sk afdhal n nader f henry l hunt s ribavirinfree regimen with sofosbuvir and velpatasvir is associated with high efficacy and improvement of patientreported outcomes in patients with genotypes  and  chronic hepatitis c results from astral and  clinical trials clin infect dis  oct   pmid  view in pubmed jiang zg feldbrügge l tapper eb popov y ghaziani t afdhal n robson sc mukamal kj letter would aspirin alleviate fibrosis in alcoholic liver disease authors reply aliment pharmacol ther  jul  pmid  view in pubmed sarrazin c dvorysobol h svarovskaia es doehle bp pang ps chuang sm ma j ding x afdhal nh kowdley kv gane ej lawitz e brainard dm mchutchison jg miller md mo h prevalence of resistanceassociated substitutions in hcv nsa nsb or ns and outcomes of treatment with ledipasvir and sofosbuvir gastroenterology  sep e pmid  view in pubmed patwardhan vr jiang zg risechneiman y piatkowski g afdhal nh mukamal k curry mp tapper eb serum ammonia in associated with transplantfree survival in hospitalized patients with acutely decompensated cirrhosis j clin gastroenterol  apr  pmid  view in pubmed kaswala dh lai m afdhal nh fibrosis assessment in nonalcoholic fatty liver disease nafld in  dig dis sci  may  pmid  view in pubmed tapper eb challies t nasser i afdhal nh lai m the performance of vibration controlled transient elastography in a us cohort of patients with nonalcoholic fatty liver disease am j gastroenterol  may  pmid  pmcid pmc view in pubmed pubmed central tapper eb sengupta n hunink mg afdhal nh lai m erratum costeffective evaluation of nonalcoholic fatty liver disease with nafld fibrosis score and vibrationcontrolled transient elastography am j gastroenterol  mar  pmid  view in pubmed jiang zg tapper eb connelly ma pimentel cf feldbrügge l kim m krawczyk s afdhal n robson sc herman ma otvos jd mukamal kj lai m steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease liver int  aug  pmid  pmcid pmc view in pubmed pubmed central tapper eb hunink mg afdhal nh lai m sengupta n costeffectiveness analysis risk stratification of nonalcoholic fatty liver disease nafld by the primary care physician using the nafld fibrosis score plos one  e pmid  pmcid pmc view in pubmed pubmed central saab s park sh mizokami m omata m mangia a eggleton e zhu y knox sj pang p subramanian m kowdley k afdhal nh safety and efficacy of ledipasvirsofosbuvir for the treatment of genotype  hepatitis c in subjects aged  years or older hepatology  apr  pmid  view in pubmed welzel tm reddy kr flamm sl denning j lin m hyland r pang ps mchutchison jg charlton m everson gt zeuzem s afdhal n ontreatment hcv rna in patients with varying degrees of fibrosis and cirrhosis in the solar trial antivir ther   pmid  view in pubmed jiang zg feldbrügge l tapper eb popov y ghaziani t afdhal n robson sc mukamal kj aspirin use is associated with lower indices of liver fibrosis among adults in the united states aliment pharmacol ther  mar  pmid  view in pubmed tapper eb catana am sethi n mansuri d sethi s vong a afdhal nh direct costs of care for hepatocellular carcinoma in patients with hepatitis c cirrhosis cancer  mar   pmid  view in pubmed wilder jm jeffers lj ravendhran n shiffman ml poulos j sulkowski ms gitlin n workowski k zhu y yang jc pang ps mchutchison jg muir aj howell c kowdley k afdhal n reddy kr safety and efficacy of ledipasvirsofosbuvir in black patients with hepatitis c virus infection a retrospective analysis of phase  data hepatology  feb  pmid  pmcid pmc view in pubmed pubmed central foster gr afdhal n roberts sk bräu n gane ej pianko s lawitz e thompson a shiffman ml cooper c towner wj conway b ruane p bourlière m asselah t berg t zeuzem s rosenberg w agarwal k stedman ca mo h dvorysobol h han l wang j mcnally j osinusi a brainard dm mchutchison jg mazzotta f tran tt gordon sc patel k reau n mangia a sulkowski m sofosbuvir and velpatasvir for hcv genotype  and  infection n engl j med  dec   pmid  view in pubmed pimentel cf jiang zg otsubo t feldbrügge l challies tl nasser i robson s afdhal n lai m poor intertest reliability between ck kits as a biomarker of nash dig dis sci  mar  pmid  pmcid pmc available on  view in pubmed pubmed central tapper eb sengupta n hunink mg afdhal nh lai m costeffective evaluation of nonalcoholic fatty liver disease with nafld fibrosis score and vibration controlled transient elastography am j gastroenterol  sep  pmid  view in pubmed giannini eg afdhal nh sigal sh muir aj reddy kr vijayaraghavan s elkashab m romerogómez m dusheiko gm iyengar m vasey sy campbell fm theodore d noncirrhotic thrombocytopenic patients with hepatitis c virus characteristics and outcome of antiviral therapy j gastroenterol hepatol  aug  pmid  view in pubmed alqahtani sa afdhal n zeuzem s gordon sc mangia a kwo p fried m yang jc ding x pang ps mchutchison jg pound d reddy kr marcellin p kowdley kv sulkowski m safety and tolerability of ledipasvirsofosbuvir with and without ribavirin in patients with chronic hepatitis c virus genotype  infection analysis of phase iii ion trials hepatology  jul  pmid  view in pubmed jain s rajasingham r noubary f coonahan e schoeplein r baden r curry m afdhal n kumar s pollock nr performance of an optimized paperbased test for rapid visual measurement of alanine aminotransferase alt in fingerstick and venipuncture samples plos one  e pmid  pmcid pmc view in pubmed pubmed central sethi n tapper eb vong a sethi s rourke m afdhal nh direct costs of firstgeneration protease inhibitors for the treatment of genotype  chronic hepatitis c viral infection j viral hepat  dec  pmid  view in pubmed charlton m everson gt flamm sl kumar p landis c brown rs fried mw terrault na oleary jg vargas he kuo a schiff e sulkowski ms gilroy r watt kd brown k kwo p pungpapong s korenblat km muir aj teperman l fontana rj denning j arterburn s dvorysobol h brandtsarif t pang ps mchutchison jg reddy kr afdhal n ledipasvir and sofosbuvir plus ribavirin for treatment of hcv infection in patients with advanced liver disease gastroenterology  sep  pmid  view in pubmed reddy kr bourlière m sulkowski m omata m zeuzem s feld jj lawitz e marcellin p welzel tm hyland r ding x yang j knox s pang p dvorysobol h subramanian gm symonds w mchutchison jg mangia a gane e mizokami m pol s afdhal n ledipasvir and sofosbuvir in patients with genotype  hepatitis c virus infection and compensated cirrhosis an integrated safety and efficacy analysis hepatology  jul  pmid  view in pubmed tapper eb afdhal nh vibrationcontrolled transient elastography a practical approach to the noninvasive assessment of liver fibrosis curr opin gastroenterol  may  pmid  view in pubmed jiang zg tsugawa y tapper eb lai m afdhal n robson sc mukamal kj lowfasting triglyceride levels are associated with noninvasive markers of advanced liver fibrosis among adults in the united states aliment pharmacol ther  jul  pmid  view in pubmed younossi zm stepanova m marcellin p afdhal n kowdley kv zeuzem s hunt sl treatment with ledipasvir and sofosbuvir improves patientreported outcomes results from the ion  and  clinical trials hepatology  jun  pmid  view in pubmed younossi zm stepanova m afdhal n kowdley kv zeuzem s henry l hunt sl marcellin p improvement of healthrelated quality of life and work productivity in chronic hepatitis c patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir j hepatol  aug  pmid  view in pubmed buti m fung s gane e afdhal nh flisiak r gurel s flaherty jf martins eb yee lj dinh p bornstein jd mani subramanian g janssen hl george j marcellin p longterm clinical outcomes in cirrhotic chronic hepatitis b patients treated with tenofovir disoproxil fumarate for up to  years hepatol int  apr  pmid  pmcid pmc view in pubmed pubmed central foster g afdhal nh karayiannis p thursz m welcome to the new all electronic journal of viral hepatitis j viral hepat  jan  pmid  view in pubmed afdhal nh bacon br patel k lawitz ej gordon sc nelson dr challies tl nasser i garg j wei lj mchutchison jg accuracy of fibroscan compared with histology in analysis of liver fibrosis in patients with hepatitis b or c a united states multicenter study clin gastroenterol hepatol  apr e pmid  view in pubmed afdhal nh a fixeddose combination of sofosbuvir and ledipasvir for hepatitis c virus genotype  gastroenterol hepatol n y  dec  pmid  pmcid pmc view in pubmed pubmed central bonder a tapper eb afdhal nh contemporary assessment of hepatic fibrosis clin liver dis  feb  pmid  view in pubmed curry mp forns x chung rt terrault na brown r fenkel jm gordon f oleary j kuo a schiano t everson g schiff e befeler a gane e saab s mchutchison jg subramanian gm symonds wt denning j mcnair l arterburn s svarovskaia e moonka d afdhal n sofosbuvir and ribavirin prevent recurrence of hcv infection after liver transplantation an openlabel study gastroenterology  jan e pmid  view in pubmed patwardhan vr sengupta n bonder a lau d afdhal nh treatment cessation in noncirrhotic eantigen negative chronic hepatitis b is safe and effective following prolonged antiviral suppression with nucleosidesnucleotides aliment pharmacol ther  oct  pmid  view in pubmed tapper eb krajewski k lai m challies t kane r afdhal n lau d simple noninvasive biomarkers of advanced fibrosis in the evaluation of nonalcoholic fatty liver disease gastroenterol rep oxf  nov  pmid  pmcid pmc view in pubmed pubmed central lin jc habersetzer f rodrigueztorres m afdhal n lawitz ej paulson ms zhu y subramanian gm mchutchison jg sulkowski m wyles dl schooley rt interferon induced protein  kinetics in treatmentnaive versus treatmentexperienced patients receiving interferonfree therapy for hepatitis c virus infection implications for the innate immune response j infect dis  dec   pmid  pmcid pmc available on  view in pubmed pubmed central tapper eb castera l afdhal nh fibroscan vibrationcontrolled transient elastography where does it stand in the united states practice clin gastroenterol hepatol  jan  pmid  view in pubmed donovan lm kress wl strnad lc sarwar a patwardhan v piatkowski g tapper eb afdhal nh low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status clin gastroenterol hepatol  jan  pmid  view in pubmed afdhal nh theodore d reply to pmid  gastroenterology  jul  pmid  view in pubmed afdhal n zeuzem s kwo p chojkier m gitlin n puoti m romerogomez m zarski jp agarwal k buggisch p foster gr bräu n buti m jacobson im subramanian gm ding x mo h yang jc pang ps symonds wt mchutchison jg muir aj mangia a marcellin p ledipasvir and sofosbuvir for untreated hcv genotype  infection n engl j med  may   pmid  view in pubmed afdhal n reddy kr nelson dr lawitz e gordon sc schiff e nahass r ghalib r gitlin n herring r lalezari j younes zh pockros pj di bisceglie am arora s subramanian gm zhu y dvorysobol h yang jc pang ps symonds wt mchutchison jg muir aj sulkowski m kwo p ledipasvir and sofosbuvir for previously treated hcv genotype  infection n engl j med  apr   pmid  view in pubmed foster g karayiannis p afdhal n editorial j viral hepat  feb  pmid  view in pubmed bonder a afdhal n utilization of fibroscan in clinical practice curr gastroenterol rep  feb  pmid  view in pubmed colagreco jp bailey de fitzpatrick jj musil cm afdhal nh lai m watchful waiting role of disease progression on uncertainty and depressive symptoms in patients with chronic hepatitis c j viral hepat  oct  pmid  pmcid pmc view in pubmed pubmed central afdhal nh zeuzem s schooley rt thomas dl ward jw litwin ah razavi h castera l poynard t muir a mehta sh dee l graham c church dr talal ah sulkowski ms jacobson im the new paradigm of hepatitis c therapy integration of oral therapies into best practices j viral hepat  nov  pmid  pmcid pmc view in pubmed pubmed central afdhal nh dusheiko gm giannini eg chen pj han kh mohsin a rodrigueztorres m rugina s bakulin i lawitz e shiffman ml tayyab gu poordad f kamel ym brainsky a geib j vasey sy patwardhan r campbell fm theodore d eltrombopag increases platelet numbers in thrombocytopenic patients with hcv infection and cirrhosis allowing for effective antiviral therapy gastroenterology  feb e pmid  view in pubmed tapper eb afdhal nh is  the new  perspectives on virology natural history and treatment for hepatitis c genotype  j viral hepat  oct  pmid  view in pubmed poordad f lawitz e reddy kr afdhal nh hézode c zeuzem s lee ss calleja jl brown rs craxi a wedemeyer h nyberg l nelson dr rossaro l balart l morgan tr bacon br flamm sl kowdley kv deng w koury kj pedicone ld dutko fj burroughs mh alves k wahl j brass ca albrecht jk sulkowski ms effects of ribavirin dose reduction vs erythropoietin for boceprevirrelated anemia in patients with chronic hepatitis c virus genotype  infectiona randomized trial gastroenterology  nov e pmid  view in pubmed afdhal nh fibroscan in the diagnosis of hepatitis c virus infection gastroenterol hepatol n y  aug  pmid  pmcid pmc view in pubmed pubmed central lee ck perezatayde ar mitchell pd raza r afdhal nh jonas mm serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a united states cohort the boston childrens hospital experience j pediatr  oct e pmid  view in pubmed mcgowan ce monis a bacon br mallolas j goncales fl goulis i poordad f afdhal n zeuzem s piratvisuth t marcellin p fried mw a global view of hepatitis c physician knowledge opinions and perceived barriers to care hepatology  apr  pmid  pmcid pmc view in pubmed pubmed central kowdley kv lawitz e crespo i hassanein t davis mn demicco m bernstein de afdhal n vierling jm gordon sc anderson jk hyland rh dvorysobol h an d hindes rg albanis e symonds wt berrey mm nelson dr jacobson im sofosbuvir with pegylated interferon alfaa and ribavirin for treatmentnaive patients with hepatitis c genotype infection atomic an openlabel randomised multicentre phase  trial lancet  jun   pmid  view in pubmed lawitz e lalezari jp hassanein t kowdley kv poordad ff sheikh am afdhal nh bernstein de dejesus e freilich b nelson dr dieterich dt jacobson im jensen d abrams ga darling jm rodrigueztorres m reddy kr sulkowski ms bzowej nh hyland rh mo h lin m mader m hindes r albanis e symonds wt berrey mm muir a sofosbuvir in combination with peginterferon alfaa and ribavirin for noncirrhotic treatmentnaive patients with genotypes   and  hepatitis c infection a randomised doubleblind phase  trial lancet infect dis  may  pmid  view in pubmed giannini eg afdhal nh eltrombopag in patients with chronic liver disease expert opin pharmacother  apr  pmid  view in pubmed sulkowski ms poordad f manns mp bronowicki jp rajender reddy k harrison sa afdhal nh sings hl pedicone ld koury kj sniukiene v burroughs mh albrecht jk brass ca jacobson im anemia during treatment with peginterferon alfabribavirin and boceprevir analysis from the serine protease inhibitor therapy  sprint trial hepatology  mar  pmid  view in pubmed bonder a afdhal nh biopsy no more changing the screening and diagnostic algorithm for hepatitis c clin gastroenterol hepatol  mar  pmid  view in pubmed marcellin p gane e buti m afdhal n sievert w jacobson im washington mk germanidis g flaherty jf aguilar schall r bornstein jd kitrinos km subramanian gm mchutchison jg heathcote ej regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis b a year openlabel followup study lancet  feb   pmid  view in pubmed li s vriend le nasser ia popov y afdhal nh koziel mj schuppan d exley ma alatrakchi n hepatitis c virusspecific tcellderived transforming growth factor beta is associated with slow hepatic fibrogenesis hepatology  dec  pmid  pmcid pmc view in pubmed pubmed central clark pj thompson aj zhu q vock dm zhu m patel k harrison sa naggie s ge d tillmann hl urban tj shianna k fellay j goodman z noviello s pedicone ld afdhal n sulkowski m albrecht jk goldstein db mchutchison jg muir aj erratum to the association of genetic variants with hepatic steatosis in patients with genotype  chronic hepatitis c infection dig dis sci  sep  pmid  view in pubmed afdhal nh fibroscan transient elastography for the measurement of liver fibrosis gastroenterol hepatol n y  sep  pmid  pmcid pmc view in pubmed pubmed central afdhal nh giannini eg tayyab g mohsin a lee jw andriulli a jeffers l mchutchison j chen pj han kh campbell f hyde d brainsky a theodore d eltrombopag before procedures in patients with cirrhosis and thrombocytopenia n engl j med  aug   pmid  view in pubmed afdhal nh management of nonalcoholic fatty liver disease a yearold man with probable nonalcoholic fatty liver disease weight reduction liver biopsy or both jama  aug   pmid  view in pubmed fried mw navarro vj afdhal n belle sh wahed as hawke rl doo e meyers cm reddy kr effect of silymarin milk thistle on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy a randomized controlled trial jama  jul   pmid  pmcid pmc view in pubmed pubmed central lai m afdhal nh clinical utility of interleukinb testing in patients with genotype  hepatology  jul  pmid  view in pubmed kanwal f befeler a chari rs marrero j kahn j afdhal n morgan t roberts l mohanty sr schwartz j vanthiel d li j zeringue a dibisceglie a potentially curative treatment in patients with hepatocellular cancerresults from the liver cancer research network aliment pharmacol ther  aug  pmid  view in pubmed jacobson im pawlotsky jm afdhal nh dusheiko gm forns x jensen dm poordad f schulz j a practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis c j viral hepat  may  suppl  pmid  view in pubmed bonder a afdhal n evaluation of liver lesions clin liver dis  may  pmid  view in pubmed clark pj thompson aj zhu q vock dm zhu m patel k harrison sa naggie s ge d tillmann hl urban tj shianna k fellay j goodman z noviello s pedicone ld afdhal n sulkowski m albrecht jk goldstein db mchutchison jg muir aj the association of genetic variants with hepatic steatosis in patients with genotype  chronic hepatitis c infection dig dis sci  aug  pmid  pmcid pmc view in pubmed pubmed central kornek m lynch m mehta sh lai m exley m afdhal nh schuppan d circulating microparticles as diseasespecific biomarkers of severity of inflammation in patients with hepatitis c or nonalcoholic steatohepatitis gastroenterology  aug  pmid  pmcid pmc view in pubmed pubmed central mehta sh kirk gd astemborski j sulkowski ms afdhal nh thomas dl stability of liver fibrosis among hcvinfected injection drug users antivir ther   pmid  pmcid pmc view in pubmed pubmed central clark pj thompson aj zhu m vock dm zhu q ge d patel k harrison sa urban tj naggie s fellay j tillmann hl shianna k noviello s pedicone ld esteban r kwo p sulkowski ms afdhal n albrecht jk goldstein db mchutchison jg muir aj interleukin b polymorphisms are the only common genetic variants associated with lowdensity lipoprotein cholesterol ldlc in genotype chronic hepatitis c and determine the association between ldlc and treatment response j viral hepat  may  pmid  pmcid pmc view in pubmed pubmed central tapper eb cohen eb patel k bacon b gordon s lawitz e nelson d nasser ia challies t afdhal n levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis c virus infection clin gastroenterol hepatol  aug e pmid  pmcid pmc view in pubmed pubmed central lai m afdhal nh editorial staging liver fibrosis in hepatitis c a challenge for this decade am j gastroenterol  dec  pmid  view in pubmed martin cr blanco pg keach jc petz jl zaman mm bhaskar kr cluettebrown je gautam s sheth s afdhal nh lindor kd freedman sd the safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis  a pilot study aliment pharmacol ther  jan  pmid  pmcid pmc view in pubmed pubmed central reddy kr belle sh fried mw afdhal n navarro vj hawke rl wahed as doo e meyers cm rationale challenges and participants in a phase ii trial of a botanical product for chronic hepatitis c clin trials  feb  pmid  pmcid pmc view in pubmed pubmed central byrnes v miller a lowry d hill e weinstein c alsop d lenkinski r afdhal nh effects of antiviral therapy and hcv clearance on cerebral metabolism and cognition j hepatol  mar  pmid  view in pubmed howell cd gorden a ryan ka thompson aj ibrahim c fried m afdhal nh mchutchison jg shianna kv goldstein db shuldiner ar mitchell bd single nucleotide polymorphism upstream of interleukin b associated with phase  and phase  of early viral kinetics in patients infected with hcv genotype  j hepatol  mar  pmid  pmcid pmc view in pubmed pubmed central cárdenas a ginès p marotta p czerwiec f oyuang j guevara m afdhal nh tolvaptan an oral vasopressin antagonist in the treatment of hyponatremia in cirrhosis j hepatol  mar  pmid  view in pubmed sherman ke flamm sl afdhal nh nelson dr sulkowski ms everson gt fried mw adler m reesink hw martin m sankoh aj adda n kauffman rs george s wright ci poordad f responseguided telaprevir combination treatment for hepatitis c virus infection n engl j med  sep   pmid  pmcid pmc view in pubmed pubmed central goldenmason l bambha km cheng l howell cd taylor mw clark pj afdhal n rosen hr natural killer inhibitory receptor expression associated with treatment failure and interleukinb genotype in patients with chronic hepatitis c hepatology  nov  pmid  pmcid pmc view in pubmed pubmed central schrieber sj hawke rl wen z smith pc reddy kr wahed as belle sh afdhal nh navarro vj meyers cm doo e fried mw differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis c drug metab dispos  dec  pmid  pmcid pmc view in pubmed pubmed central klibansky da mehta sh curry m nasser i challies t afdhal nh transient elastography for predicting clinical outcomes in patients with chronic liver disease j viral hepat  feb e pmid  view in pubmed thompson aj clark pj singh a ge d fellay j zhu m zhu q urban tj patel k tillmann hl naggie s afdhal nh jacobson im esteban r poordad f lawitz ej mccone j shiffman ml galler gw king jw kwo py shianna kv noviello s pedicone ld brass ca albrecht jk sulkowski ms goldstein db mchutchison jg muir aj genomewide association study of interferonrelated cytopenia in chronic hepatitis c patients j hepatol  feb  pmid  pmcid pmc view in pubmed pubmed central qu kz zhang k ma w li h wang x zhang x giles f lai m afdhal nh albitar m ubiquitinproteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease j gastroenterol hepatol  apr  pmid  view in pubmed qu kz zhang k li h afdhal nh albitar m circulating micrornas as biomarkers for hepatocellular carcinoma j clin gastroenterol  apr  pmid  view in pubmed afdhal nh bacon br brown rs chronic hepatitis b integrating longterm treatment data and strategies to improve outcomes in clinical practice gastroenterol hepatol n y  mar  suppl  pmid  pmcid pmc view in pubmed pubmed central afdhal nh mchutchison jg zeuzem s mangia a pawlotsky jm murray js shianna kv tanaka y thomas dl booth dr goldstein db hepatitis c pharmacogenetics state of the art in  hepatology  jan  pmid  view in pubmed darling jm aerssens j fanning g mchutchison jg goldstein db thompson aj shianna kv afdhal nh hudson ml howell cd talloen w bollekens j de wit m scholliers a fried mw quantitation of pretreatment serum interferoninducible protein improves the predictive value of an ilb gene polymorphism for hepatitis c treatment response hepatology  jan  pmid  pmcid pmc view in pubmed pubmed central conjeevaram hs wahed as afdhal n howell cd everhart je hoofnagle jh changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis c gastroenterology  feb  pmid  view in pubmed kornek m popov y libermann ta afdhal nh schuppan d human t cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells hepatology  jan  pmid  pmcid pmc view in pubmed pubmed central pritchett s cardenas a manning d curry m afdhal nh the optimal cutoff for predicting large oesophageal varices using transient elastography is disease specific j viral hepat  apr e pmid  view in pubmed urban tj thompson aj bradrick ss fellay j schuppan d cronin kd hong l mckenzie a patel k shianna kv mchutchison jg goldstein db afdhal n ilb genotype is associated with differential expression of intrahepatic interferonstimulated genes in patients with chronic hepatitis c hepatology  dec  pmid  pmcid pmc view in pubmed pubmed central cohen eb afdhal nh ultrasoundbased hepatic elastography origins limitations and applications j clin gastroenterol  oct  pmid  view in pubmed malik r lai m sadiq a farnan r mehta s nasser i challies t schuppan d afdhal n comparison of transient elastography serum markers and clinical signs for the diagnosis of compensated cirrhosis j gastroenterol hepatol  sep  pmid  view in pubmed sulkowski ms shiffman ml afdhal nh reddy kr mccone j lee wm herrine sk harrison sa poordad ff koury k deng w noviello s pedicone ld brass ca albrecht jk mchutchison jg hepatitis c virus treatmentrelated anemia is associated with higher sustained virologic response rate gastroenterology  nov  e pmid  view in pubmed schuppan d gorrell md klein t mark m afdhal nh the challenge of developing novel pharmacological therapies for nonalcoholic steatohepatitis liver int  jul  pmid  view in pubmed afdhal nh curry mp early tips to improve survival in acute variceal bleeding n engl j med  jun   pmid  view in pubmed thompson aj fellay j patel k tillmann hl naggie s ge d urban tj shianna kv muir aj fried mw afdhal nh goldstein db mchutchison jg variants in the itpa gene protect against ribavirininduced hemolytic anemia and decrease the need for ribavirin dose reduction gastroenterology  oct  pmid  pmcid pmc view in pubmed pubmed central wang hh portincasa p afdhal nh wang dq lith genes and genetic analysis of cholesterol gallstone formation gastroenterol clin north am  jun  viiviii pmid  view in pubmed lai m afdhal nh health care quality measurement in the care of patients with cirrhosis clin gastroenterol hepatol  aug  pmid  view in pubmed thompson aj muir aj sulkowski ms ge d fellay j shianna kv urban t afdhal nh jacobson im esteban r poordad f lawitz ej mccone j shiffman ml galler gw lee wm reindollar r king jw kwo py ghalib rh freilich b nyberg lm zeuzem s poynard t vock dm pieper ks patel k tillmann hl noviello s koury k pedicone ld brass ca albrecht jk goldstein db mchutchison jg interleukinb polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype  hepatitis c virus gastroenterology  jul e pmid  view in pubmed mchutchison jg manns mp muir aj terrault na jacobson im afdhal nh heathcote ej zeuzem s reesink hw garg j bsharat m george s kauffman rs adda n di bisceglie am telaprevir for previously treated chronic hcv infection n engl j med  apr   pmid  view in pubmed poynard t afdhal nh perspectives on fibrosis progression in hepatitis c an à la carte approach to risk factors and staging of fibrosis antivir ther   pmid  view in pubmed rustgi vk lee wm lawitz e gordon sc afdhal n poordad f bonkovsky hl bengtsson l chandorkar g harding m mcnair l aalyson m alam j kauffman r gharakhanian s mchutchison jg merimepodib pegylated interferon and ribavirin in genotype  chronic hepatitis c pegylated interferon and ribavirin nonresponders hepatology  dec  pmid  view in pubmed hawke rl schrieber sj soule ta wen z smith pc reddy kr wahed as belle sh afdhal nh navarro vj berman j liu qy doo e fried mw silymarin ascending multiple oral dosing phase i study in noncirrhotic patients with chronic hepatitis c j clin pharmacol  apr  pmid  pmcid pmc view in pubmed pubmed central benhamou y afdhal nh nelson dr shiffman ml halliman dg heise j chun e pockros pj a phase iii study of the safety and efficacy of viramidine versus ribavirin in treatmentnaïve patients with chronic hepatitis c viser results hepatology  sep  pmid  view in pubmed celli jp turner bs afdhal nh keates s ghiran i kelly cp ewoldt rh mckinley gh so p erramilli s bansil r helicobacter pylori moves through mucus by reducing mucin viscoelasticity proc natl acad sci u s a  aug   pmid  pmcid pmc view in pubmed pubmed central becker l salameh w sferruzza a zhang k ng chen r malik r reitz r nasser i afdhal nh validation of hepascore compared with simple indices of fibrosis in patients with chronic hepatitis c virus infection in united states clin gastroenterol hepatol  jun  pmid  view in pubmed afdhal nh lok as di bisceglie am clinical decisions management of incidental hepatitis c virus infection n engl j med  apr   pmid  view in pubmed malik r chang m bhaskar k nasser i curry m schuppan d byrnes v afdhal n the clinical utility of biomarkers and the nonalcoholic steatohepatitis crn liver biopsy scoring system in patients with nonalcoholic fatty liver disease j gastroenterol hepatol  apr  pmid  view in pubmed kirk gd astemborski j mehta sh spoler c fisher c allen d higgins y moore rd afdhal n torbenson m sulkowski m thomas dl assessment of liver fibrosis by transient elastography in persons with hepatitis c virus infection or hivhepatitis c virus coinfection clin infect dis  apr   pmid  pmcid pmc view in pubmed pubmed central manning ds afdhal nh eusguided liver biopsy a procedure looking for an indication gastrointest endosc  mar  pt  pmid  view in pubmed khokhar a afdhal nh therapeutic strategies for chronic hepatitis b virus infection in  am j med  dec  suppls pmid  view in pubmed mehta sh lau b afdhal nh thomas dl exceeding the limits of liver histology markers j hepatol  jan  pmid  pmcid pmc view in pubmed pubmed central popov y zaks j grall f liebermann t afdhal nh schuppan d t cell derived membrane microparticles containing emmprin induce profibrolytic activation in hepatic stellate cells hepatology  a afdhal nh manning d diagnosis of liver fibrosis in  and beyond gastroenterol clin biol  sep  suppl  pmid  view in pubmed li h sferruzza a qu kz afdhal nh lai m radcliff js bender ra utility of four tumor markers alone and in combination for detection of hepatocellular carcinoma afp afpl dcp and cystatin j clin oncol  may  suppl pmid  view in pubmed manning ds afdhal nh diagnosis and quantitation of fibrosis gastroenterology  may  pmid  view in pubmed afdhal nh levine r brown r jrfreilich b obrien m brass c colchicine versus peginterferon alfa b long term therapy results of the  year copilot trial hepatology  s malik r lai m bhaskarin curry m schuppan d afdhal nh identification of biomakers that measure disease activity in patients with nonalcoholic fatty liver disease hepatology  s afdhal nh manns mp lennox jj nguyen t berg t dalekos gn trepo c roberts sk prieto m sorbel j anderson j mondou e rousseau f the antiviral response to tenofovir disoproxil fumarate tdf is comparable in lamivudine lamnaive and lamexperienced subjects treated for chronic hepatitis b chb gastroenterology  a afdhal n mchutchison j brown r jacobson i manns m poordad f weksler b esteban r thrombocytopenia associated with chronic liver disease j hepatol  jun  pmid  view in pubmed schuppan d afdhal nh liver cirrhosis lancet  mar   pmid  pmcid pmc view in pubmed pubmed central cardenas a lowe r oh s bodkin s kenney t lamorte ww afdhal nh hemodynamic effects of substance p and its receptor antagonist rp in anesthetized rats with carbon tetrachlorideinduced cirrhosis scand j gastroenterol  mar  pmid  view in pubmed zinkin nt grall f bhaskar k otu hh spentzos d kalmowitz b wells m guerrero m asara jm libermann ta afdhal nh serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease clin cancer res  jan   pmid  view in pubmed patel k nelson dr rockey dc afdhal nh smith km oh e hettinger k vallée m dev a smithriggs m mchutchison jg correlation of fibrospect ii with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis c clin gastroenterol hepatol  feb  pmid  view in pubmed shah nl zacharias i khettry u afdhal n gordon fd methasteronassociated cholestatic liver injury clinicopathologic findings in  cases clin gastroenterol hepatol  feb  pmid  view in pubmed lai m afdhal n challies t liver masses and eosinophilia liver int  jan  pmid  view in pubmed mchutchison jg dusheiko g shiffman ml rodrigueztorres m sigal s bourliere m berg t gordon sc campbell fm theodore d blackman n jenkins j afdhal nh eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis c n engl j med  nov   pmid  view in pubmed afdhal nh esteban r introduction thrombocytopenia in chronic liver disease  treatment implications and novel approaches aliment pharmacol ther  nov  suppl  pmid  view in pubmed afdhal nh mchutchison jg review article pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis c infection aliment pharmacol ther  nov  suppl  pmid  view in pubmed mchutchison jg bacon br gordon sc lawitz e shiffman m afdhal nh jacobson im muir a aladhami m morris ml lekstromhimes ja efler sm davis hl phase b randomized doubleblind doseescalation trial of cpg  in patients with chronic hepatitis c virus hepatology  nov  pmid  view in pubmed sulkowski ms mehta sh torbenson ms higgins y brinkley sc de oca rm moore rd afdhal nh thomas dl rapid fibrosis progression among hivhepatitis c viruscoinfected adults aids  oct   pmid  view in pubmed afdhal nh mchutchison jg shiffman ml rodrigues torres m dusheioko gm sigal s white s blackman n cambell f dickens t eltrombopag raises platelet count in  weeks in patients with hcv and significant thrombocytopenia hepatology  a malik r afdhal n stiffness and impedance the new liver biomarkers clin gastroenterol hepatol  oct  pmid  view in pubmed shah mbbrown rs barski t freilich b levine ra afdhal nh  tolerability of lowdose peginterferon alfab in hepatitis c patients with cirrhosis results from the copilot trial hepatology  a jacobson im brown rs freilich b afdhal n kwo py santoro j becker s wakil ae pound d godofsky e strauss r bernstein d flamm s pauly mp mukhopadhyay p griffel lh brass ca peginterferon alfab and weightbased or flatdose ribavirin in chronic hepatitis c patients a randomized trial hepatology  oct  pmid  view in pubmed malik r farnan r lai m freitag h schuppan d afdhal nh comparison of fibroscan apri astalt and clinical signs as non invasive predictors of cirrhosis hepatology  a byrnesvm miller a hille weinstein david alsop lenkinski re afdhal nh  the cerebral metabolic and cognitive effects of pegylated interferon pifn and hepatitis c viral hcv clearance hepatology  a lai m hyatt bj nasser i curry m afdhal nh the clinical significance of persistently normal alt in chronic hepatitis b infection j hepatol  dec  pmid  view in pubmed pockros pj schiff er shiffman ml mchutchison jg gish rg afdhal nh makhviladze m huyghe m hecht d oltersdorf t shapiro da oral idn an antiapoptotic caspase inhibitor may lower aminotransferase activity in patients with chronic hepatitis c hepatology  aug  pmid  view in pubmed lai m afdhal nh noninvasive markers of liver fibrosis advances in digestive diseases editor howden cw     byrnes v shi h kiryu s rofsky nm afdhal nh the clinical outcome of small  mm arterially enhancing nodules on mri in the cirrhotic liver am j gastroenterol  aug  pmid  view in pubmed celli jp turner bs afdhal nh ewoldt rh mckinley gh bansil r erramilli s rheology of gastric mucin exhibits a phdependent solgel transition biomacromolecules  may  pmid  view in pubmed goodman zd becker rl pockros pj afdhal nh progression of fibrosis in advanced chronic hepatitis c evaluation by morphometric image analysis hepatology  apr  pmid  view in pubmed becker l afdhal nh nonivasive diagnosis of nash nonalcoholic steatohepatitis nash editors bataller r caballeria j   pockros pj jeffers l afdhal n goodman zd nelson d gish rg reddy kr reindollar r rodrigueztorres m sullivan s blatt lm farisyoung s final results of a doubleblind placebocontrolled trial of the antifibrotic efficacy of interferongammab in chronic hepatitis c patients with advanced fibrosis or cirrhosis hepatology  mar  pmid  view in pubmed cárdenas a curry m afdhal nh the not so good effects of nitric oxide inhibition with methylene blue in cirrhosis and ascites dig dis sci  apr  pmid  view in pubmed afdhal nh curry m technology evaluation a critical step in the clinical utilization of novel diagnostic tests for liver fibrosis j hepatol  apr  pmid  view in pubmed esmat g metwally m zalata kr gadalla s abdelhamid m abouzied a shaheen aa elraziky m khatab h elkafrawy s mikhail n magder ls afdhal nh strickland gt evaluation of serum biomarkers of fibrosis and injury in egyptian patients with chronic hepatitis c j hepatol  apr  pmid  view in pubmed conjeevaram hs kleiner de everhart je hoofnagle jh zacks s afdhal nh wahed as race insulin resistance and hepatic steatosis in chronic hepatitis c hepatology  jan  pmid  view in pubmed fontana rj kleiner de bilonick r terrault n afdhal n belle sh jeffers lj ramcharran d ghany mg hoofnagle jh modeling hepatic fibrosis in african american and caucasian american patients with chronic hepatitis c virus infection hepatology  oct  pmid  view in pubmed mchutchison j poynard t afdhal n fibrosis as an end point for clinical trials in liver disease a report of the international fibrosis group clin gastroenterol hepatol  oct  pmid  view in pubmed conjeevaram hs fried mw jeffers lj terrault na wileylucas te afdhal n brown rs belle sh hoofnagle jh kleiner de howell cd peginterferon and ribavirin treatment in african american and caucasian american patients with hepatitis c genotype  gastroenterology  aug  pmid  view in pubmed wang hh afdhal nh gendler sj wang dq evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in muc transgenic mice gastroenterology  jul  pmid  view in pubmed afdhal nh noninvasive markers of liver fibrosis gastroenterol hepatol n y  jun  pmid  view in pubmed mueller s afdhal nh schuppan d iron hcv and liver cancer hard metal setting the pace gastroenterology  jun  pmid  view in pubmed kamal sm moustafa kn chen j fehr j abdel moneim a khalifa ke el gohary la ramy ah madwar ma rasenack j afdhal nh duration of peginterferon therapy in acute hepatitis c a randomized trial hepatology  may  pmid  view in pubmed kamal sm turner b he q rasenack j bianchi l al tawil a nooman a massoud m koziel mj afdhal nh progression of fibrosis in hepatitis c with and without schistosomiasis correlation with serum markers of fibrosis hepatology  apr  pmid  view in pubmed wilson le torbenson m astemborski j faruki h spoler c rai r mehta s kirk gd nelson k afdhal n thomas dl progression of liver fibrosis among injection drug users with chronic hepatitis c hepatology  apr  pmid  view in pubmed kamal sm fouly ae kamel rr hockenjos b al tawil a khalifa ke he q koziel mj el naggar km rasenack j afdhal nh peginterferon alfab therapy in acute hepatitis c impact of onset of therapy on sustained virologic response gastroenterology  mar  pmid  view in pubmed oh s afdhal nh antiviral therapy for treatment naïve patients with hepatitis c virus infect dis clin north am  mar  vivii pmid  view in pubmed byrnes v afdhal n challies t greenstein pe drug induced liver injury secondary to interferonbeta ifnbeta in multiple sclerosis ann hepatol  janmar  pmid  view in pubmed khokar as byrnes v afdhal nh  future therapies for hepatitis c current hepatitis reports   wang hh afdhal nh wang dq overexpression of estrogen receptor alpha increases hepatic cholesterogenesis leading to biliary hypersecretion in mice j lipid res  apr  pmid  view in pubmed kelleher tb afdhal n assessment of liver fibrosis in coinfected patients j hepatol   suppls pmid  view in pubmed hari s conjeevaram university of michigan ann arbor mi michael w fried university of north carolina chapel hill nc lennox j jeffers va medical center miami fl norah terrault ucsf san francisco ca thelma e wileylucas rush university medical center chicago il nezam afdhal beth israel deaconess medical center boston ma robert s brown jr new york presbyteriancolumbia presbyterian center new york ny steve h belle university of pittsberg pittsburgh pa patricia r robuck niddk nih bethesda md charles d howell university of maryland baltimore md peginterferon alfaa and ribavirin in african american and caucasian patients with chronic hepatitis c genotype  hepatology  a michelle lai benjamin hyatt bidmc boston ma nezam afdhal bidmc boston ma role of liver biopsy in patients with normal alt and high hbv dna hepatology  a ira m jacobson weill medical college of cornell university new york ny robert s brown columbia university college of physicians  surgeons new york ny bradley freilich baptist medical center kansas city mo nezam afdhal beth israel deaconess medical center boston ma pauk kwo indian university school of medicine indianapolis in john santoro atlantic gastroenterology associates egg harbor township nj scott becker austin gastroenterology pa austin tx adil wakil california pacific medical center san francisco ca david pound indianapolis gastroenterology rsch indianapolis in eliot godofsky bach and godofsky md pa bradenton fl robert strauss northwest georgia gastroenterology associates pc marietta ga david bernstein north shore university hospital mahasset ny steven flamm northwestern memorial hospital chicago il natrajan bala gastroenterology consultants houston tx victor araya albert einstein medical center philadelphia pa mitchell davis south florida center of gastroenterology pa wellington fl howard monsour liver specialists of texas houston tx john vierling cedarssinai medical center los angeles ca fredric regenstein tulane university medical school new orleans la vijay balan mayo clinic phoenix az michael dragutsky gi consultants of the midshouth memphis tn michael epstein digestive disorders associates annapolis md robert w herring nashville tn raymond rubin atlanta gastroenterology assoc atlanta ga greg galler kelseyseubold clinic houston tx mary pat pauly kaiser permanente sacramento ca louis h griffel clifford a brass scheringplough research institute kenilworth nj the winr s group kenilworth nj weightbased ribavirin dosing wbd increases sustained viral response svr in patients with chronic hepatitis c chc final results of the winr study a us community based trial hepatology  a yury popov bidmc harvard medical school boston ma sebastian meuller brad turner bidmc harvard medical school boston ma n zinkin bidmc boston ma i nasser h masuzaki bidmc harvard medical school boston ma j vriereck dept or neurology and biophysics boston medical center boston ma j hamilton dept or neurology and biophysics boston medical center boston ma j flier nezam afdhal detlef schuppan bidmc harvard medical school boston ma mice overexpressing bhydroxysterioddehydrogenase hsd in adipose tisure develop nash and progressive pericentral fibrosis on a high fat diet hepatology  a john g mchutchinson duke univ durham nc bruce r bacon st louis univ hopsital st louis mo stuart c gordon henry ford hospital detroit mi eric lawitz alamo medical research san antonio tx mitchell shiffman medical college of richmond virginia richmond va nezam h afdhal beth israel deaconess medical center boston ma ira m jacobson cornell univ new york ny andrew muir duke university durham nc susan m efler a vicari k myette nav ahluwalia pp murzenok coley pharmalbach art m krieg coley pharmaceutical group ottawa canada immunophenotyping profile of cpg  a new tlr agonist antiviral for hepatitis c hepatology  a noah t zinkin beth israel deaconess medical center boston ma hasan h otu dimitrios spentzos manuel aivado meghan wells beth israel deaconess medical center proteomics core boston ma brett d kalmowitz kr bhaskar beth israel deaconess medical center boston ma towia a libermann beth israel deaconess medical center proteomics core boston ma nezam h afdhal beth israel deaconess medical center boston ma a combined proteomic and serologic approach to diagnosis of hepatocellular carcinoma hepatology  vol no a john mchutchinson duke univeristy durham nc bruce bacon st louis university hospital st louis mo stuart c gordon henry ford hospital detroit mi eric lawitz alamo medical research san antonio tx michell shiffman medical college of virginia richmond va nezam h afdhal beth israel deaconess medical center boston ma ira jacobson cornell university new york ny andrew muir duke univeristy duram nc susan elfer coley pharmaceutical group ottawa canada mohammed aladhami coley pharmaceuticals group wellesley ma heather davis coley pharmaceutical group ottawa canada tess schmalbach coley pharmaceutical group wellesley ma relationship of hcv rna responses to cpg  a tlr agonist pharmacodynamics and patient characteristics hepatology  a xiaojian zhou idenix pharmaceuticals inc cambridge ma maribel rodigueztorres funacion de investigacion de diego santurce eric lawitz alamo medical research san antonio tx eliot godofsky bach  godofsky bradenton fl nezam afdhal beth israel deaconess medical center boston ma barbara fielman constance george chao steven knox nathaniel a brown idenix pharmaceuticals cambridge ma asence of effect of pegylated interferon alfab on the pharmacokenetics of valopicitabine nm in patients with chronic hepatitis c hepatology  a christopher obrien university of miami miami fl eliot godofsky bach  godofsky brandenton fl maribel rodrigueztorres fundacion de investigacion de diego sanurce puerto rico nezam afdhal beth israel deaconess medical center boston ma sc pappas st lukes episcopal hospital randomized trial of valopicitabine nm alone or with peginterferon vs retreatment with peginterferon plus ribavirin peginfrbv in hepatitis c patients with pervious nonresponse to pegifnrbv first interi results hepatology  vol no a nezam afdhal beth israel deaconess medical center boston ma andres cardenas bidmc boston ma monica guevara univ barcelona barcelona spain peter gross unvi car gustav carus dresden dresden germany joseph varbalis georgetown univ medical center washington dc thomas berl robert schrier univ of colorado health science center denver co daniel bichet hospital de sacre courer de montreal montreal canada lynn wagoner univ of cinncinnati heart and vascular center cincinnati oh john ouyang cesare orlandi frank czerwiec otsuka maryland research institute rockville md randomized placebocontrolled trial of tolvaptan a novel vreceptor antagonist in hyponatremia results of the salt  trial with emphasis on efficacy and safety in cirrohosis hepatology  a john gross stephanie johnson mayo clinic rochester mn paul kwo indiana u school of medicine indianapolis in nezam h afdhal beth israel deaconess medical center boston ma stven flamm northwestern u department of medicine chicago il terry therneau the renew investigators mayo clinic rochester mn doubledose peginterferon alfab with wieghtbased ribavirin improves response for interferonribavirin nonresponders with hepatitis c final results of renew hepatology  vol no a asim khokhar rory farnan chelsea macfarlane bidmc boston ma bruce bacon slu st louis mo john mchutchison duke univ medical center durham nc nezam afdhal beth israel deaconess medical center boston ma liver stiffness and biomarkers correlation with cirrhosis protal hypertension and hepatic synthetic function hepatology  a kelleher tb afdhal n noninvasive assessment of liver fibrosis clin liver dis  nov  vii pmid  view in pubmed hong z chasan b bansil r turner bs bhaskar kr afdhal nh atomic force microscopy reveals aggregation of gastric mucin at low ph biomacromolecules  novdec  pmid  view in pubmed curry mp afdhal nh use of growth factors with antiviral therapy for chronic hepatitis c clin liver dis  aug  vii pmid  view in pubmed maribel rodigueztorres eric lawitz eliot godofsky nezam afdhal george chao barbara fielman constance steven knox nathaniel a brown valopitabine nm alone and in combination with peginterferon in patients with genotype  chronic hepatitis c preliminary results from an ongoing phase ii multicenter study gastroenterology  p helen h wang nezam h afdhal david q wang impaired gallbladder motility and accelerated cholesterol crystallization and gallstone formation in mice overexpressing human mucin gene  hmuc gastroenterology  p bruce r bacon john g mchutchison stuart c gordon nezam h afdhal ira m jacobson mitchell schiffman andrew muir arthur m krieg susan elfer mary lou morris john whisnant mohammed aladhami heather davis tess schmalbach safety pharmacodynamic pd and pharmacokinetic pk profiles of cpg  actilontm a novel tlr agonist comparison in normal volenteers and hcv infected individuals gastroenterology  p stephen a harrison chris fincke sangik oh thomas kelleher katie smith nezam afdhal combined serological and clinical measures enhance the noninvasive diagnosis of advanced fibrosis in nafld gastroenterology  p sanaa kamal ahmed al tawil qi he khalifa sayed kheiry el naggar sarah hakam wafaa saleh manal el sayed leonardo bianchi mohamed madwar nezam afdhal long term cohort study of the clinical and histologicalprogression of hcv gastroenterology  p paul j pockros lennox jeffers nezam afdhal zachary d goodman david nelson robert gish rajender reddy robert reindollar maribel rodigueztorres sima farisyoung sara sullivan lawrence m blatt final result of a doubleblind placebocontrolled trial of the antibibrotic efficacy of inf gammab in chronic hepatitis c patients with advanced fibrosis or cirrosis gastroenterology  p xiaojian zhou nezam afdhal eliot godofsky jules dienstag vinod rustgi lawton schick lael duncan barbara fielman constance george chao nathaniel a brown pharmacokinetics and pharmacodynamics of valopictabine nm a new nucleoside hcv polymerase inhibitor results from a phase iii doseescalation trial in patients with hcv infection gastroenterology  a noah t zinkin hassan h otu dimitrios spentzos manuel aivado meghan wells towia a liberman nezam h afdhal proteomic profiling of hepatocellular carcinoma with selditof mass spectrometry in patients with chronic liver disease gastroenterology  a valerie byrnes anne miller cheryl weinstein erin hill robert lenkinski david alsop nezam h afdhal cerebral metabolic and neuropsychiatric effects of pegylated interferon pifn therapy in hepatitis c gastroenterology  p celli j gregor b turner b afdhal nh bansil r erramilli s viscoelastic properties and dynamics of porcine gastric mucin biomacromolecules  mayjun  pmid  view in pubmed kelleher tb mehta sh bhaskar r sulkowski m astemborski j thomas dl moore re afdhal nh prediction of hepatic fibrosis in hivhcv coinfected patients using serum fibrosis markers the shasta index j hepatol  jul  pmid  view in pubmed n afdhal m rodrigueztorres e lawitz e godofsky g chao b fielman s knox m brown department of medicine beth israel deaconess medical center boston ma usa fundacion de investigacion de diego santurce pr usa alamo medical research san antonio tx usa bach  godofsky bradenton fl usa idenix pharmaceuticals cambridge ma usa enhanced antiviral efficacy for valopicitabine nm plus peginterferon in hepatitis c patients with hcv genotype infection results of a phase iia multicenter trial journal of hepatology   m curry a cardenas nh afdhal liver center beth israel deaconess medical center boston ma usa effect of maintenance pegintron therapy on portal hypertension and its complications results from the copilot study journal of hepatology   strickland gt tanamly md tadros f labeeb s makld h nessim d mikhail n magder ls afdhal nh medhat a abdelhamid m twoyear results of a randomised doubleblinded trial evaluating silymarin for chronic hepatitis c dig liver dis  jul  pmid  view in pubmed xj zhou n afdhal e godofsky j dienstag v rustgi l schick d mcinery ba fielman na brown idenix pharmaceuticals inc cambridge ma usa beth israel deaconess medical center boston ma usa bach  godofsky bradenton fl usa massachusetts general hospital boston ma usa metropolitan research fairfax va usa university of massachusetts health center worcester ma usa northwest medical specialties tacoma wa usa pharmacokinetics and pharmacodynamics of valopicitabinenm a new nucleoside hcv polymerase inhibitor results from a phase iii doseescalation trial in patients with hcv infection journal of hepatology   vm byrnes h shi s kiryu nm rofsky nh afdhal department of gastroenterology beth israel deaconess medical center boston ma usa deparment of radiology beth israel deaconess medical center boston ma usa the fate of arterial enhancing nodules on mri in the cirrhotic liver journal of hepatology   cárdenas a afdhal nh khwaja k an unusual cause of abdominal pain in a patient with hepatitis c cirrhosis gut  apr   pmid  pmcid pmc view in pubmed pubmed central gish rg afdhal nh dieterich dt reddy kr management of hepatitis c virus in special populations patient and treatment considerations clin gastroenterol hepatol  apr  pmid  view in pubmed sulkowski ms mehta sh torbenson m afdhal nh mirel l moore rd thomas dl hepatic steatosis and antiretroviral drug use among adults coinfected with hiv and hepatitis c virus aids  mar   pmid  view in pubmed afdhal n can serum markers be used to reliably detect liver fibrosis nat clin pract gastroenterol hepatol  mar  pmid  view in pubmed kelleher tb afdhal n maintenance therapy for chronic hepatitis c curr gastroenterol rep  feb  pmid  view in pubmed pockros pj shiffman ml schiff er sulkowski ms younossi z dieterich dt wright tl mody sh tang kl goon bl bowers pj leitz g afdhal nh epoetin alfa improves quality of life in anemic hcvinfected patients receiving combination therapy hepatology  dec  pmid  view in pubmed tanamly md tadros f labeeb s makld h shehata m mikhail n abdelhamid m shehata m abubaki l medhat a magder ls afdhal nh strickland gt randomised doubleblinded trial evaluating silymarin for chronic hepatitis c in an egyptian village study description and month results dig liver dis  nov  pmid  view in pubmed nezham afdhal beth israel deaconess medical center boston ma bradley freilich kansas digetsive diseases kanas city mo robert levine syracuse univeristy syracuse ny maritin black temple university philadelphia pa robert brown jr columbia college of physicians and surgeons new york ny howard monsour gi and liver associates granbury tx michael obrien boston medical center boston ma clifford brass schering plough kenilworth nj colchicine versus peg intron long term copilot trial interim analysis of clinical outcomes at year  hepatology  a nezam afdhal beth israel deaconess medical center boston ma eliot godofsky bach  godofsky brandenton fl jules dienstag massachusetts general hospital boston ma vinod rustgi metropolitan research fairfax va lawton schick university of massachusetts health center worcester ma david mceniry northwest medical specialties pllc tacoma wa xiaojian zhou george chao christopher fang barbara fielman maureen myers nathaniel brown idenix pharmaceuticals cambridge ma final phase iii trial results for nm a new polymerase inhibitor for hepatitis c antiviral efficancy and tolerance in patients with hcv infection including previous interferon failures hepatology  a john g mchutchison duke university durham nc bruce r bacon saint louis university school of medicine saint louis mo stuart c gordon william beaumont hospital royal oak mi nezam h afdhal beth israel deaconess medical center boston ma ira m jacobson cornell university new york ny andrew muir duke univeristy durham nc arthur m krieg susan efler mohammed aladhami heather l davis tess k schmalback coley pharmaceutical group inc wellesley ma human pharmacological activity of a new tlr agonist antiviral cpg  actilon hepatology the official journal of the american association for the study of liver disease  a alex s befer saint louis university st louis mo jorge a marrero univeristy of michigan ann arbor mi ravi s chari vanderbilt univeristy nashville tn lewis roberts mayo clinic rochester mn nezam afdhal harvard university beth israel deaconess hopsital boston ma david van thiel loyola univeristy chicago il adrian m di bisceglie saint louis univeristy st louis mo the epidemiology and survival of patients with hepatocellular carcinoma in the united states  a prelininary report from the liver cancer network hepatology  a oh s afdhal nh antiviral therapy for treatment naïve patients with hepatitis c virus gastroenterol clin north am  sep  viii pmid  view in pubmed afdhal nh biopsy or biomarkers is there a gold standard for diagnosis of liver fibrosis clin chem  aug  pmid  view in pubmed durantemangoni e wang r shaulov a he q nasser i afdhal n koziel mj exley ma hepatic cdd expression in hepatitis c virus infection and recognition by resident proinflammatory cddreactive t cells j immunol  aug   pmid  view in pubmed wang hh afdhal nh wang dq estrogen receptor alpha but not beta plays a major role in betaestradiolinduced murine cholesterol gallstones gastroenterology  jul  pmid  view in pubmed graham cs curry m he q afdhal n nunes d fleming c horsburgh r craven d sherman ke koziel mj comparison of hcvspecific intrahepatic cd t cells in hivhcv versus hcv hepatology  jul  pmid  view in pubmed afdhal nh nunes d evaluation of liver fibrosis a concise review am j gastroenterol  jun  pmid  view in pubmed afdhal nh dieterich dt pockros pj schiff er shiffman ml sulkowski ms wright t younossi z goon bl tang kl bowers pj epoetin alfa maintains ribavirin dose in hcvinfected patients a prospective doubleblind randomized controlled study gastroenterology  may  pmid  view in pubmed wang hh afdhal nh gendler sj wang dq lack of the intestinal muc mucin impairs cholesterol uptake and absorption but not fatty acid uptake in muc mice am j physiol gastrointest liver physiol  sep g pmid  view in pubmed keyur patel david r nelson nezam afdhal esther oh katie smith john g mchutchison don rockey prospective evaluation of a serum fibrospect ii panel to predict fibrosis in chronic hcv patients gastroenterology  a valerie m byrnes honghu shi shigeru kiryu neil m rofsky nezam h afdhal  the fate of arterial enhancing nodules on mri in the cirrhotic liver gastroenterology  a helen h wang nezam h afdhal david qh wang overexpression of estrogen receptor alfa eralfainhibits the negative feedback regulation of cholesterol ch biosynthesis and increases newly synthesized ch leading to biliary ch hypersecretion gastroenterology  a brett d kalmowitz lorenzo rossaro howard p monsour jr robert s brown jr mohamad a elkurdi kr bhaskar nezam h afdhal  desgamma carboxyprothrombin pivkaiiand alfafetoprotein in cirrhosis secondary to hcv gastroenterology  a wang dq afdhal nh genetic analysis of cholesterol gallstone formation searching for lith gallstone genes curr gastroenterol rep  apr  pmid  view in pubmed paul j pockros mitchell l shiffman eugene r schiff nezam h afdhal mark s sulkowski zobair younossi teresa wright douglas t dieterich janice jenkins gerhard j leitz peter j bowers longterm treatment with epoetin alfa maintains ribavirin dose and hemoglobin levels in anemic hcvinfected patients receiving interferonribavirin ifnrbvtherapy gastroenterology  a eugene r schiff paul pockros mitchell l shiffman john mchutchison robert gish nezam h afdhal manana makhviladze mira huyghe david hecht tilman oltersdorf david a shapiro oral idn an antiapoptotic caspase inhibitor lowers aminotransferases in hcv patients gastroenterology  a eric j lawitz stephen a harrison norma s cantu shailesh c kadakia kp ganeshappa frank adams mitchell davis richard sperling naoky tsai andrei gasic tarum kothari james cox barry sanders bruce silverman elias ghandour jeffrey medoff vajravel prasad nezam afdhal mark mailliard michael curry alamo study group the effect of amantadine on sustained virologic response when added to pegylated interferon alfa b  weight based ribavirin in previous nonresponders and relapsers gastroenterology  a eliot godofsky nezam afdhal vinod rustgi lawton shick lael duncan xiaojian zhou george chao christopher fang barbara fielman maureen myers nathaniel brown a phase iii dose escalation trial assessing tolerance pharmacokinetics and antiviral activity of nm a novel antiviral treatment for hepatitis c gastroenterology  a eric j lawitz norma s cantu stephen a harrison shailesh kadakia frank adams mitchell davis richard sperling naoky tsai andrei gasic tarum kothari kp ganeshappa james cox barry sanders bruce silverman elias ghandour jeffrey medoff nezam afdhal mark mailliard michael curry alamo study group the outcome of hepatitis c therapy in african americans and hispanics with persistently normal transaminases gastroenterology  a afdhal nh role of epoetin alfa in maintaining ribavirin dose gastroenterol clin north am  mar  suppls pmid  view in pubmed afdhal nh cao x bansil r hong z thompson c brown b wolf d interaction of mucin with cholesterol enriched vesicles role of mucin structural domains biomacromolecules  marapr  pmid  view in pubmed wang hh afdhal nh gendler sj wang dq targeted disruption of the murine mucin gene  decreases susceptibility to cholesterol gallstone formation j lipid res  mar  pmid  view in pubmed byrnes v cárdenas a afdhal n hanto d symptomatic focal nodular hyperplasia during pregnancy a case report ann hepatol  janmar  pmid  view in pubmed afdhal nh the natural history of hepatitis c semin liver dis   suppl  pmid  view in pubmed kalmowitz bd afdhal nh maintenance therapies for hepatitis c current hepatitis reports   yang c zeisberg m lively jc nyberg p afdhal n kalluri r integrin alphabeta and alphabeta are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment cancer res  dec   pmid  view in pubmed nezam h afdhal angela klopfer linda tang zobair younossi hemoglobin increase is independently associated with increased healthrelated quality of life hrqlin anemic interferonribavirin ifnrbvtreated hepatitis c virus hcvinfected patients treated with epoetin alfa hepatology  a nezam h afdhal betty goon kevin smith zobair younossi epoetin alfa epo improves and maintains healthrelated quality of life hrql in anemic hcvinfected patients receiving interferonribavirin ifnrbv hrql results from the proactive study hepatology  a nezam h afdhal david q wang the blockade of estrogen action by fulvestrant ici  prevents cholesterol gallstone formation in the mouse hepatology  a stuart c gordon bruce r bacon ira m jacobson mitchell l shiffman nezam h afdhal rosie z yu john g mchutchison jesse kwoh treatment of chronic hepatitis c with isis  an antisense inhibitor of hcv given for  weeks hepatology  a hari s conjeevaram david e kleiner nezam afdhal robert s brown michael w fried charles d howell lennox j jeffers nora terrault thelma e wiley chris cherry steve belle jay h hoofnagle race insulin resistance visceral adiposity and hepatic steatosis in genotype  patients with chronic hepatitis c hepatology  a changqing yang jiyao wang michael zeisberg mary soubasakos nezam h afdhal raghu kalluri epithelial to mesenchymal transition during liver fibrosis hepatology  a eric j lawitz norma s cantu mitchell davis nezam afdhal michael curry mark mailliard frank adams naoky tsai andrei gasic tarun kothari kp ganeshappa james cox bruce silverman shailesh c kadakia triple therapy compared to standard pegylated interferon alfa b  weight based ribavirin for previous nonresponders and relapsers with chronic hepatitis c hepatology  a john b gross terry m therneau stephanie m johnson paul y kwo nezam h afdhal steven l flamm renew trial investigators the renew trial a national multicenter study of highdose peginterferon alfab  ribavirin for nonresponders with hepatitis c hepatology  a eric j lawitz norma s cantu mitchell davis nezam afdhal michael curry mark mailliard frank adamsnaoky tsaitarun kothari kp ganeshappa james cox bruce silverman shailesh c kadakia triple therapy compared to standard pegylated interferon alfa b  weight based ribavirin for treatment naive chronic hepatitis c tristar trial final results hepatology  a afdhal nh diagnosing fibrosis in hepatitis c is the pendulum swinging from biopsy to blood tests hepatology  may  pmid  view in pubmed nezam h afdhal douglas t dieterich paul j pockros eugene r schiff mitchell l shiffman mark s sulkowski teresa wright zobair younossi peter j bowers epoetin alfa treatment of anemic hcvinfected patients allows for maintenance of ribavirin dose increases hemoglobin levels and improves quality of life vs placebo a randomized doubleblind multicenter study gastroenterology  a furqaan ahmed ira m jacobson robert s brown jr nezam afdhal raymond rubin james spivey bradley freilich frederic regenstein david bernstein robert doig clifford brass winr study group clinical significance of pegylated interferon induced neutropenia results from the winr trial gastroenterology  a helen h wang nezam h afdhal david qh wang targeted disruption of mucin gene  muc decreases susceptibility to cholesterol ch gallstone formation in mice gastroenterology  a changqing yang hikaru sugimoto sudhakar akulppalli mauricio giraldo nezam afdhal michael zeisberg raghu kalluri effects of bmp on liver regeneration after partial hepatectomy in mice gastroenterology  a afdhal nh aga gtp project  viral hepatitis section  afdhal nh hepatic fibrosis  afdhal nh diseases of the gallbladder and bile ducts cecils textbook of medicine goldman l ed  yang c zeisberg m mosterman b sudhakar a yerramalla u holthaus k xu l eng f afdhal n kalluri r liver fibrosis insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors gastroenterology  jan  pmid  view in pubmed sc gordon br bacon im jacobson ml shiffman nh afdhal jg mchutchison tj kwoh fa dorr a phase ii week study of isis  an antisense inhibitor of hcv for the treatment of chronic hepatitis c hepatology  a changqing yang hikaru sugimoto mauricio giraldo nezam afdhal michael zeisberg raghu kalluri bone morphogenic protein a member of the tgfbeta superfamily accelerates liver regeneration after partial hepatectomy in mice hepatology  a ira jacobson robert s brown jr nezam afdhal raymond rubin james spivey bradley freilich frederick regenstein david bernstein robert doig clifford brass clinical correlates of hcv genotype and viral load findings from the winr trial hepatology  a changqing yang michael zeisberg nezam afdhal raghu kalluri new insights into the migratory behavior of human hepatocellular carcinoma hepg cells hepatology  a ira jacobson robert s brown jr nezam afdhal raymond rubin james spivey bradley freilich frederic regenstein david bernstein robert doig clifford brass characterictics of hcv infection in africanamericans findings from the winr trial hepatology  a nezam h afdhal bradley freilich martin black robert levine clifford brass comparison of therapy with pegintron mcgkg versus colchicine mg bid in  patients with cirrhosis and hcv interim data from copilot hepatology  a john b gross paul kwo nezam afdhal renew investigator group interim results in the renew trial a dose comparison study of highdose peginterferon alfab and ribavirin for interferonribavirin nonresponders with chronic hepatitis c hepatology  a robert brown ira jacobson nezam afdhal ray rubin james spivey frederic regenstein david bernstein clifford brass bradley freilich racialethnic differences in hematologic toxicity of pegylated interferon and ribavirin therapy analysis of the winr trial hepatology  a nezam h afdhal christopher b obrien scott c oshana lisa m dunkle potent antihbv activity of ach correlated with day pharmacokinetics and safety predictions for activity against ymdd mutant strains hepatology  a helen h wang nezam h afdhal david q wang increased fecal neutral sterol and bile acid excretion confers resistance to dietinduced cholesterol ch cholelithiasis in gallstoneresistant akr mice hepatology  a nezam h afdhal hiro masuzaki bradley turner imad nasser jeffrey flier transgenic mice with  betahydroysteroid dehydrogenase type  overexpression in adipocytes develop fatty liver disease hepatology  a vijayan balan ira m jacobson robert brown jr nezam afdhal r rubin james spivey bradley freilich david e bernstein virender sharma clifford brass winr study group regional and racial variation of hepatitis c genotypes in the united states hepatology  a michael zeisberg kyle kramer changqing yang nazia akhtar nezam afdhal raghu kalluri liver fibrosis extracellular matrix microenvironment regulates hepatocyte behavior hepatology  a guo w kurze v huber t afdhal nh beyer k hamilton ja a solidstate nmr study of phospholipidcholesterol interactions sphingomyelincholesterol binary systems biophys j  sep  pmid  pmcid pmc view in pubmed pubmed central byrnes v afdhal n cholangiocarcinoma of the hepatic hilum klatskin tumor curr treat options gastroenterol  apr  pmid  view in pubmed wang dq afdhal nh good cholesterol bad cholesterol role of oxysterols in biliary tract diseases gastroenterology  jul  pmid  view in pubmed oh s afdhal nh hepatic fibrosis are any of the serum markers useful curr gastroenterol rep  feb  pmid  view in pubmed bernard chasan zhenning hong rama bansil bradley turner k ramakrishnan bhaskar nezam afdhal atomic force microscopy of gastric mucin bulletin of the american physical society march poster presentation at the annual meeting of the american physical society seattle wa   afdhal nh biliary tract disease primary care medicine noble j ed   afdhal nh geahigan t management of the patient with chronic hepatitis chronic viral hepatitis diagnosis and therapeutics wu gy koff rs eds   afdhal nh clinical implications hepatitis in the new millenium predictors of response to hcv  zhenning hong rama bansil nezam h afdhal k ramakrishnan bhaskar bradley s turner formation and growth of cholesterol crystals in polymer solutions from model bile biophysical journal poster presentation at the th annual meeting of the biophysical society boston ma feb    a afdhal nh primary care medicine rd edition primary care medicine rd edition noble j ed   curry mp afdhal nh hepatic adenoma  afdhal nh flamm s imperial ja malet pf tong m pappas sc campagna j pegylated kda interferon alfaa pegasys in combination with ribavirin  mycophenolate mofetil amantadine or amantadine plus ribavirin in patients that did not respond to rebetron therapy a preliminary report of a randomized  multicenter study digestive disease week presentation in atlanta ga  obrien mj keating nm elderiny s cerda s keaveny ap afdhal nh nunes dp an assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis c am j clin pathol  nov  pmid  view in pubmed nh afdhal diseases of the gallbladder and biliary tract diseases of the gallbladder and biliary tract nh afdhal ed  afdhal nh brand m apstein a cooley j hoffman j mikolich d grace n oconnor c nunes dp randomized controlled trial of interferon a mu daily plus ribavirin mg daily versus interferon a mu tiw plus ribavirin mg daily in patients with hcv who have never received previous therapy hepatology  a afdhal nh epidemiology and pathogenesis of cholesterol gallstones diseases of the gallbladder and biliary tract afdhal nh ed   afdhal nh options for nonresponders to combination therapy the nonresponding hepatitis c patient options and variables b bacon ed   afdhal nh keaveny ap nunes dp hepatitis c treatment of patients in an urban medical center hepatology  a afdhal nh curry mp noninvasive markers of hepatic fibrosis  keaveny ap afdhal nh a  year old woman with sonographic evidence of gallstones internal medicine heffner je sahn sa eds   stefan am coulter s gray b lamorte w nikelaeson s edge as afdhal nh xenogeneic transplantation of porcine hepatocytes into the ccl cirrhotic rat model cell transplant  novdec  pmid  view in pubmed afdhal nh crohns and stones am j gastroenterol  may  pmid  view in pubmed nunes dp afdhal nh offner gd a recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time gastroenterology  apr  pmid  view in pubmed cao x bansil r bhaskar kr turner bs lamont jt niu n afdhal nh phdependent conformational change of gastric mucin leads to solgel transition biophys j  mar  pmid  pmcid pmc view in pubmed pubmed central raj v afdhal nh cholangitis in the immunosuppressed patient aids cholangiopathy  afdhal nh protecting new jerseys public health what healthcare professionals must know about hepatitis c  lowe r afdhal nh cystic diseases of biliary tract  afdhal nh bacterial fungal and granulomatous diseases of the liver therapy of digestive disorders wolfe mm ed   nunes dp anastopolous h gordon f chopra s petruff c salomons h wilson s afdhal nh double blind placebo controlled study of interferon versus interferon plus ribavirin for the treatment of hepatitis c in patients who previously failed interferon monotherapy hepatology  a afdhal nh approach to the patient with incidental gallstones  keaveny a cardenas a nunes dp edge ae afdhal nh peripheral th and th cytokine responses in patients with hcv treated with interferon and interferonribavirin hepatology  a offner gd nunes dp keates ac afdhal nh troxler rf the aminoterminal sequence of mucb contains conserved multifunctional d domains implications for tissuespecific mucin functions biochem biophys res commun  oct   pmid  view in pubmed wong dk dudley dd afdhal nh dienstag j rice cm wang l houghton m walker bd koziel mj liverderived ctl in hepatitis c virus infection breadth and specificity of responses in a cohort of persons with chronic infection j immunol  feb   pmid  view in pubmed zakko s afdhal nh treatment of acute cholecystitis  lowe r afdhal nh cholangiocarcinoma  zakko s afdhal nh clinical features and diagnosis of acute cholecystitis  keavney ap offner gd afdhal nh inducible nitric oxide is the principal isoform expressed in human gallbladder gastroenterology  a nunes dp keaveny a gunsalus r lebel md edge asb offner gd afdhal nh serum cytokine profiles in patients with chronic hcv effect of interferon treatment hepatology  a tung by afdhal nh nunes dp thummel ke kharasch ed croghan am cox pp lin m kowdley kv the effect of iron depletion on serum markers of lipid peroxidation and fibrosis in hepatitis c hepatology  a eder mi nunes dp afdhal nh offner gd tnfa stimulates mucin secretion but not mucin synthesis in human gallbladder epithelial cells gastroenterology  a nunes dp offner gd afdhal nh reduced sensitivity of hcv genotype  to interferon when coinfected with genotype  gastroenterology  a lucas w afdhal nh epidemiology of and risk factors for gallstones  nunes dp thim l niu n afdhal nh offner gd human spasmolytic polypeptide hsp significantly enhances the cholesterol crystal nucleating properties of mucin gastroenterology  a afdhal nh hcv and hiv coinfection  afdhal nh acalculous cholecystitis  afdhal nh clinicians companion iii management of hepatitis c  afdhal nh keaveny ap cohen sb nunes dp maldonado n obrien m stone pj urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis j hepatol  dec  pmid  view in pubmed cao x bansil r gantz d moore ew niu n afdhal nh diffusion behavior of lipid vesicles in entangled polymer solutions biophys j  oct  pmid  pmcid pmc view in pubmed pubmed central keates ac nunes dp afdhal nh troxler rf offner gd molecular cloning of a major human gall bladder mucin complete cterminal sequence and genomic organization of mucb biochem j  may    pt  pmid  pmcid pmc view in pubmed pubmed central salomons h keaveny ap henihan r offner g sengupta a lamorte ww afdhal nh nitric oxide and gallbladder motility in prairie dogs am j physiol  apr  pt g pmid  view in pubmed raj v afdhal nh acute cholangitis up to date in medicine gastroenterology series  keaveny a karasik m afdhal nh pancreatic and hepatobiliary infections in aids patients gastrointestinal infections lamont jt ed   keavney a afdhal nh gallstone ileus  afdhal nh complications of laparoscopic cholecystectomy  afdhal nh abnormal liver function tests for the primary care physician core curriculum in medicine  afdhal nh colorectal cancer screening core curriculum in medicine  cao x niu n offner gd nunes d bansil r wolf de afdhal nh mucin vesicle interactions are biphasic and depend on mucin glycosylated and nonglycosylated structural domains gastroenterology  a lowe r bodkin s kenney t afdhal nh substance p is not a neuromediator of splanchnic hyperemia or portal hypertension in the cirrhotic rat gastroenterology  a karasik m afdhal nh small bowel and colonic infections in aids patients gastrointestinal infections lamont jt ed   moore ew darby gh rege rv afdhal nh what prevents digestion of the gallbladder phospholipid protects against the toxic effect of taurochenodeoxycholate but not taurocholate gastroenterology  a mac mathuna p siegenberg d gibbons d gorin d obrien m afdhal na chuttani r the acute and longterm effect of balloon sphincteroplasty on papillary structure in pigs gastrointest endosc  dec  pmid  view in pubmed schroy pc wilson s afdhal n feasibility of highvolume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system am j gastroenterol  jul  pmid  view in pubmed zijlstra ai offner gd afdhal nh van overveld m tytgat gn groen ak the pronase resistance of cholesterolnucleating glycoproteins in human bile gastroenterology  jun  pmid  view in pubmed moore ew darby g afdhal nh what prevents the gallbladder from digesting itself studies of taurochenodeoxycholate toxicity gastroenterology  a afdhal nh nunes d acalculous cholecystitis consultations in gastroenterology snape wj ed   nunes d sharma a cohen s rea c offner gd apstein m afdhal nh randomized trial of interferon dose escalation for the treatment of chronic hepatitis c gastroenterology  a karasik m afdhal nh biliary tract disease primary care medicine noble j ed   offner gd nunes dp zhang f mcanany db afdhal nh alterations in gallbladder mucin gene expression in patients with cholesterol gallstones gastroenterology  a karasik m afdhal nh gastrointestinal manifestations of aids hiv infection a clinical manual libman h witzburg ra eds   koziel mj dudley d afdhal n grakoui a rice cm choo ql houghton m walker bd hla class irestricted cytotoxic t lymphocytes specific for hepatitis c virus identification of multiple epitopes and characterization of patterns of cytokine release j clin invest  nov  pmid  pmcid pmc view in pubmed pubmed central afdhal nh ostrow jd koehler r niu n groen ak veis a nunes dp offner gd interaction of bovine gallbladder mucin and calciumbinding protein effects on calcium phosphate precipitation gastroenterology  nov  pmid  view in pubmed afdhal nh niu n nunes dp bansil r cao xx gantz d small dm offner gd mucinvesicle interactions in model bile evidence for vesicle aggregation and fusion before cholesterol crystal formation hepatology  sep  pmid  view in pubmed nunes dp keates ac afdhal nh offner gd bovine gallbladder mucin contains two distinct tandem repeating sequences evidence for scavenger receptor cysteinerich repeats biochem j  aug    pt  pmid  pmcid pmc view in pubmed pubmed central offner gd nunes dp moore ew afdhal nh prostaglandin e stimulates mucin secretion and increases muc mrna levels in cultured human gallbladder epithelial cells hepatology   duzendorfer d lee v chipkin s afdhal nh karasik m hida scintigraphy as a test for small intestinal transit effect of acute hyperglycemia american journal of gastroenterology   afdhal nh carey mc new perspectives on gallstone pathogenesis and prevention journal of the irish colleges of physicians and surgeons   kenney tj stefan a nunes dp offner gd nikulasson s pouthalakis c and afdhal nh effect of substance p and its receptor antagonist cp on systemic arterial and portal pressure in normal and cirrhotic rats hepatology   karasik m dunzendorfer t lee v chipkin s afdhal nh acute hyperglycemia impairs gallbladder motility in normal but not diabetic men american journal of gastroenterology   offner gd gong d afdhal nh identification of a kilodalton human biliary concanavalin a binding protein as aminopeptidase n gastroenterology  mar  pmid  view in pubmed afdhal nh lamont jt pathogenesis of gallstones principles and practices of gastroenterology and hepatology gitnick g ed   lamont jt afdhal nh cholesterol gallstone disease from pathogenesis to prevention current opinion in gastroenterology   purdum pp afdhal nh rege r moore ew effect of mucus gel layer on phospholipid transfer across human cultured gallbladder epithelia hepatology   lataif le niu n offner gd afdhal nh interaction of biliary cholesterol with mucin gels gastroenterology  a koziel mj dudley d afdhal n choo ql houghton m ralston r walker bd hepatitis c virus hcvspecific cytotoxic t lymphocytes recognize epitopes in the core and envelope proteins of hcv j virol  dec  pmid  pmcid pmc view in pubmed pubmed central kline tj de las morenas t obrien m smith bf afdhal nh squamous metaplasia of extrahepatic biliary system in an aids patient with cryptosporidia and cholangitis dig dis sci  may  pmid  view in pubmed afdhal nh niu n gantz d small dm smith bf bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile gastroenterology  may  pmid  view in pubmed afdhal nh gong d niu n turner b lamont jt offner gd cholesterol cholelithiasis in the prairie dog role of mucin and nonmucin glycoproteins hepatology  apr  pmid  view in pubmed karasik ms dunzendorfer t lee v chipkin s afdhal nh acute hyperglycemia impairs gallbladder and small intestinal motility in normal men gastroenterology   afdhal nh gastrointestinal manifestations of the acquired immunodeficiency syndrome hiv infection a clinical manual libman h witzburg r eds   afdhal nh niu n nunes d bansil r gantz d small dm offner gd molecular basis of nucleation differences between slow and fast pronucleating proteins gastroenterology   obrien s keogan m patchett s mccormick pa afdhal n hegarty je postprandial changes in portal haemodynamics in patients with cirrhosis gut  mar  pmid  pmcid pmc view in pubmed pubmed central afdhal nh long a lennon j crowe j odonoghue dp controlled trial of antimycobacterial therapy in crohns disease clofazimine versus placebo dig dis sci  apr  pmid  view in pubmed niu n smith bf small dm afdhal nh calcium preferentially accelerates gallbladder mucin induced cholesterol monohydrate crystal nucleation rather than crystal growth in model bile gastroenterology   afdhal nh offner gd smith bf characterization of bovine gallbladder mucin amino acid sequences of tryptic peptides from the glycosylated domain of the protein core gastroenterology  nov  pmid  view in pubmed afdhal nh offner gd murray fe troxler rf smith bf isolation and characterization of peptides from the protein core of bovine gallbladder mucin gastroenterology  jun  pmid  view in pubmed afdhal nh smith bf cholesterol crystal nucleation a decadelong search for the missing link in gallstone pathogenesis hepatology  apr  pmid  view in pubmed afdhal nh smith bf pathogenesis of cholesterol gallstones viewpoints on digestive disease   gourdin tg afdhal nh niu n smith bf calcium augments binding of bilirubin to bovine gallbladder mucin hepatology   patchett se enright h afdhal n oconnell w odonoghue dp clot lysis by gastric juice an in vitro study gut  dec  pmid  pmcid pmc view in pubmed pubmed central afdhal nh kelly j mccormick pa odonoghue dp remission induction in refractory crohns disease using a high calorie whole diet jpen j parenter enteral nutr  julaug  pmid  view in pubmed keane te dillon b afdhal nh mccormack cj conservative management of perforated duodenal ulcer br j surg  jun  pmid  view in pubmed mccormick pa ramsay n afdhal n shattuck ag hillary ib tubridy d odonoghue dp serological markers of hepatitis b virus hbv infection in alcoholics and hospital controls ir j med sci  mar  pmid  view in pubmed bulger k afdhal nh odonoghue dp a colorectal cancer database computers in gastroenterology vickery r editor  afdhal nh long a tobbia i cullen a odonoghue dp immunohistochemical cal in primary colonic polyps and polyps synchronous with colorectal cancer gut  may  pmid  pmcid pmc view in pubmed pubmed central afdhal nh piggott c long aa odonoghue dp carbohydrate handling by colonic florais it pathogenic in the irritable bowel syndrome ir j med sci  jun  pmid  view in pubmed duffy mj osullivan f odonoghue d afdhal nh kelleher d ca a new marker for gastrointestinal malignancy ir j med sci  oct  pmid  view in pubmed afdhal nh chman m doyle d horgan jh obstructive sleep apnoea syndrome presenting as cardiac arrhythmia ir j med sci  mar  pmid  view in pubmed afdhal nh smith j heffernan s doyle js gaffney e acute small bowel obstruction secondary to endometriosis two case reports and a review of the literature ir med j  may  pmid  view in pubmed keatinge am johnson ah collins pb afdhal n lynch d lavin jn vitamin b b b and c status in the elderly ir med j  dec  pmid  view in pubmed this graph shows the total number of publications by year to see the data from this visualization as text click here yearpublications to return to the timeline click here local representatives can answer questions about the profiles website or help with editing a profile or issues with profile data for assistance with this profile hmshsdm faculty should contact feedbackcatalystharvardedu for faculty or fellow appointment updates and changes please ask your appointing department to contact hms for fellow personal and demographic information contact hms human resources at humanresourceshmsharvardedu for faculty personal and demographic information contact hms office for faculty affairs at facappthmsharvardedu afdhals networks click the see all links for more information and interactive visualizations concepts derived automatically from this persons publicationsantiviral agentshepatitis c chronicliver cirrhosisribavirinelasticity imaging techniquessee all  concepts coauthors people in profiles who have published with this personcurry michaelmalik razanasser imadlai michellebonder alansee all  people similar people people who share similar concepts with this personcurry michaeljonas maureendienstag juleschung raymondfisher robertsee all  people same department people who are also in this persons primary department ballou sarah bonder alan feuerstein joseph keates andrew lin steven search department physical neighbors people whose addresses are nearby this personmalik razalai michellelau darylkaufman gailpleskow douglas spotlight harvard catalyst profiles need to find people harvard catalyst profiles is the app for that sponsoring program biomedical informatics program see also atlas consulting  advice harvardtrials about harvard catalyst national ctsa consortium contact us news  events spotlights site map supported browsers questions ask us » newsletters sign up here » cite our support in your publications learn how » copyright   by the president and fellows of harvard college funded by the nihncats clinical and translational science award ctsa program grant number ultr and through institutional support from harvard university harvard medical school harvard th chan school of public health beth israel deaconess medical center boston childrens hospital brigham and womens hospital massachusetts general hospital and the dana farber cancer institute nezam h afdhal md executive profile  biography  bloomberg july    pm et biotechnology company overview of spring bank pharmaceuticals inc snapshotpeople  overviewboard memberscommittees executive profile nezam h afdhal mdchief medical officer spring bank pharmaceuticals incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background dr nezam h afdhal md has been chief medical officer of spring bank pharmaceuticals inc since november   and served as its consultant from  to november  dr afdhal serves as chief of hepatology director of liver center at beth israel deaconess medical center he serves as professor of medicine harvard medical school and director of hepatology and the liver center at beth israel deaconess medical center dr afdhal serves as a member of scientific  advisory board at angion biomedica corp dr afdhal clinical expertise focuses on the management of the complications of liver disease including cirrhosis and portal hypertension he serves as the director of a clinical trials group focusing on novel treatments of hepatitis b and c dr afdhal served as a member of scientific advisory board at ligand pharmaceuticals inc dr afdhal served as a associate professor of medicine at the harvard medical school dr afdhal has received extensive funding in the area of hcv for preclinical and clinical development and has been involved in the development of many of the leading hcv candidates in the clinical pipeline dr afdhal is on the advisory board of the american liver foundation and the massachusetts state advisory board for hcv dr afdhal served as member of strategic advisory board at medgenics inc since january   he served on the editorial board and as a reviewer for multiple journals he has published more than  papers in journals such as gastroenterology hepatology gut and journal of hepatology as well as  book chapters and two books he has spoken nationally and internationally on chronic liver disease and received many awards including the american liver foundation award for excellence and the mitchell lectureship of the royal college of physicians he is a member of the american gastroenterological association the american association for the study of liver diseases and the european association for the study of the liver dr afdhal received md degree from the royal college of surgeons in ireland and fellowship training at university college dublin and at boston university school of medicineread full background corporate headquarters  south streethopkinton massachusetts united statesphone fax  board members memberships there is no board members memberships data available education unknownother education royal college of surgeons in ireland other affiliations ligand pharmaceuticals incorporatedaevi genomic medicine incroyal college of surgeons in irelandangion biomedica corp annual compensation salarybonustotal annual compensation stocks options all other compensationexercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact spring bank pharmaceuticals inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close find a doctor symptom checker conditions medications procedures and hospitals  itriagehealthcom dr nezam afdhal  internist in boston ma  healthgrove uwyxvrby hospitals std clinics drugs more  search doctors × menu see all doctors education and trainingcontactsee more doctorsprofessional informationphysician teamingprescribing recordopen paymentsmore on healthgrove nezam afdhal in boston massachusetts education and trainingcontactsee more doctorsmoreprofessional informationphysician teamingprescribing recordopen paymentsmore on healthgrove nezam afdhal in boston massachusetts education and training contact see more doctors professional information physician teaming prescribing record open payments more on healthgrove references see all doctors guide to choosing a physician share dr nezam h afdhal hepatology address bidmc francis st ste eboston massachusetts phone   highly experienced doctor  years experienceprimary specialty hepatologyaffiliated hospitals beth israel deaconess medical center beth israel deaconess hospitalmilton inc beth israel deaconess hospital  needham cape cod hospital run a background check on nezam run a background check on nezam advertisement shareeducation and trainingfellowshipsboard certificationsmembershipsmedical publications tapper eb castera l afdhal nh fibroscan vibrationcontrolled transient elastography where does it stand in the united states practice division of gastroenterology beth israel deaconess medical center harvard medical school  jun pubmedgov advertisement sharecontact and location phone   address bidmc francis st ste eboston massachusetts  dr nezam afdhal is one of  boston internists he has been practicing for  years and specializes primarily in hepatology practicing in boston massachusetts advertisement sharesee more doctors nearbymore hepatologists in the boston area full namespecialtymedical schoolyears of experienceaddressaddress line locationidtitle fieldspecialtydusanka grbichepatology francis stwlmob eboston massachusettsdaryl t lauhepatology francis stsuite aboston massachusettsmichelle j laihepatologycolumbia university college of physicians and surgeons francis stsuite aboston massachusettsmichael p curryhepatology brookline aveboston massachusettseric b cohenhepatology francis stliver center th floorboston massachusettssanjiv choprahepatology park drlandmark center nd floor westboston massachusettstibor kriskohepatology francis stboston massachusetts see more internists in boston massachusetts › healthgrove is a health site that uses graphiq’s semantic technology to deliver deep insights via datadriven articles visualizations and research tools deep insights from health data knowledge delivered › shareprofessional informationquality reportinglicensegroup practicemorequality reporting quality reporting pqrs yes accepts medicare assignment yes ehr yes dr afdhal is a participant in medicares incentivebased physician quality reporting system meaning he voluntarily reports quality measures on patient outcomes to medicare license state license massachusetts   npi  group practice group name harvardmedicalfacultyphysicians at bethisraeldeaconessmedicalcenter number of doctors at group  group id  other doctors at this practice full nameyears of experiencespecialtyidtitle fieldanya leppinternal medicinechristina s moonophthalmologylouise p kinggynecologythomas t simopoulospain medicinealok guptatrauma surgeryjatinder s gillanesthesiologyrupa mukherjeegastroenterologyhuma faridobstetrics  gynecologyjessica l taylorinternal medicinelior levyanesthesiology advertisement sharephysician teaming the following data breaks down the shared medicare patient base between dr nezam h afdhal and his physician colleagues this shared patient population represents those who received care from both dr afdhal and a related physician within a  day time period throughout  regardless of whether this was due to a direct referral or not patients who visited dr afdhal after having seen another physician within this time period are denoted as received while patients who saw another physician after receiving care from dr afdhal are denoted as shared total unique patients receivedtotal received visitsnumber of specialties receiving fromnumber of physicians receiving frompatients receivedpatients sharedstate and county comparisonmorepatients received physicians visited before dr afdhal percent patients received by specialty patients shared physicians visited after dr afdhal percent patients shared by specialty state and county comparison the following chart displays how the number of visits and unique patients received by dr nezam h afdhal from other physicians compared to the county and state averages for his specialty label nametotal received visitstotal unique patientsidnezam h afdhalsuffolk countymassachusetts sharemedicare part d prescribing record this section is a breakdown of dr afdhals medicare prescribing records in  the most recent data available from medicare for this provider it should be noted that the data may not be representative of dr afdhals entire prescribing pattern all comparisons are made to the average hepatologist in the state average cost per prescription usdbelow the state average for hepatologists  usd medicare prescription drug expenses united states dollarstotal claim countbeneficiary count common medications prescribed drug nameconditions addressedtotal claim countaverage cost per claimidphysiciannadololhigh blood pressure myocardial infarction heart attack angina heart failure united states dollars prescription counts by year yeartotal claim countmedicare prescription drug expensesstatespecialty average claim countidprovider usd usd usd usd advertisement sharepharmaceutical company payments the affordable care act requires cms to collect information from applicable manufacturers and group purchasing organizations gpos on their financial relationships with physicians this data is collected and made publicly available under the federally run open payments program which currently spans payments made to physicians through the years  to  in total dr nezam h afdhal has received  usd from pharmaceutical companies medical device manufacturers and grouppurchasing organizations gpos between august  and december  these contributions were provided in  payments from eight unique companies dr afdhal has received approximately the same amount in payments as the average hepatologist in massachusetts over this time period total payment value united states dollarsnumber of individual paymentsnumber of dates paid note by law national provider identifier npi numbers are not disclosed in the open payments data source for each payment recipient thus payment records found below are linked through the best match of available physician contact information reasons for payment companies making payment company nameduns numbertotal payment valueidgilead sciences incgilead sciences incuwyxvrby united states dollarsmerck sharp  dohme corporationmerck sharp  dohme corporation united states dollarsabbvie incabbvie inc united states dollarsglaxosmithkline llcglaxosmithkline llc united states dollarsbristolmyers squibb companybristolmyers squibb company united states dollarsjanssen research  development llcjanssen research  development llc united states dollarsboehringer ingelheim pharmaceuticals incboehringer ingelheim pharmaceuticals inc united states dollarsvertex pharmaceuticals incvertex pharmaceuticals incorporated united states dollars payments by datethe following calendar depicts the total value of pharmaceutical payments to dr afdhal on all dates between august  and december  when payments were received darker squares indicate greater payment amounts ‹‹  rewind calendar ‹  previous month next month  › note total payment values on each date have been rounded to the nearest dollarindividual payment records date of paymentassociated productstotal payment valuereason for paymentcompany name organizationidfull name united states dollarsconsulting feesbristolmyers squibb companyhumira viekira synthroid androgel lupron united states dollarsconsulting feesabbvie inc united states dollarsconsulting feesbristolmyers squibb company united states dollarshonorariagilead sciences inc united states dollarsfood and beveragesbristolmyers squibb companyhumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarstravel and lodgingabbvie inc united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb companyhumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarstravel and lodgingabbvie inc united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb companyhumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarstravel and lodgingabbvie inc united states dollarsfood and beveragesbristolmyers squibb companyhumira viekira synthroid androgel lupron united states dollarstravel and lodgingabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inc united states dollarstravel and lodgingbristolmyers squibb company united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarsfood and beveragesgilead sciences incdaklinza united states dollarsfood and beveragesbristolmyers squibb companydaklinza united states dollarsfood and beveragesbristolmyers squibb company united states dollarstravel and lodginggilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarsfood and beveragesgilead sciences incnonproduct united states dollarsconsulting feesmerck sharp  dohme corporation united states dollarstravel and lodginggilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarshonorariagilead sciences incnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsconsulting feesmerck sharp  dohme corporationhumira viekira synthroid androgel lupron united states dollarsconsulting feesabbvie inchumira viekira synthroid androgel lupron united states dollarstravel and lodgingabbvie incnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporation united states dollarsconsulting feesgilead sciences inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inchumira viekira synthroid androgel lupron united states dollarsfood and beveragesabbvie inc united states dollarshonorariagilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarshonorariagilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarsconsulting feesgilead sciences inc united states dollarshonorariagilead sciences inc united states dollarsconsulting feesabbvie incnonproduct united states dollarsconsulting feesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporation united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesgilead sciences inc united states dollarshonorariagilead sciences incbaraclude united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesgilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences incsovaldi united states dollarsconsulting feesgilead sciences inc united states dollarstravel and lodginggilead sciences incbaraclude united states dollarsfood and beveragesbristolmyers squibb company united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarstravel and lodginggilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsgiftsgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarsfood and beveragesgilead sciences inc united states dollarstravel and lodginggilead sciences incbaraclude united states dollarsfood and beveragesbristolmyers squibb companybaraclude united states dollarsfood and beveragesbristolmyers squibb companyvictrelis united states dollarstravel and lodgingmerck sharp  dohme corporationvictrelis united states dollarsfacultyspeaker feesmerck sharp  dohme corporationvictrelis united states dollarstravel and lodgingmerck sharp  dohme corporationvictrelis united states dollarstravel and lodgingmerck sharp  dohme corporationvictrelis united states dollarstravel and lodgingmerck sharp  dohme corporationvictrelis united states dollarsfood and beveragesmerck sharp  dohme corporationvictrelis united states dollarstravel and lodgingmerck sharp  dohme corporationsovaldi united states dollarsconsulting feesgilead sciences incbaraclude united states dollarsfood and beveragesbristolmyers squibb companybaraclude united states dollarsfood and beveragesbristolmyers squibb company united states dollarsconsulting feesbristolmyers squibb companyolysio united states dollarsconsulting feesjanssen research  development llcolysio united states dollarsfood and beveragesjanssen research  development llc united states dollarstravel and lodgingbristolmyers squibb company united states dollarstravel and lodgingbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb companybaraclude united states dollarsfood and beveragesbristolmyers squibb company united states dollarsconsulting feesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarstravel and lodgingabbvie inc united states dollarstravel and lodgingabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarstravel and lodgingabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb companynonproduct united states dollarsconsulting feesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsconsulting feesmerck sharp  dohme corporation united states dollarsconsulting feesglaxosmithkline llcnonproduct united states dollarsconsulting feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfacultyspeaker feesmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarsfood and beveragesmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporationnonproduct united states dollarstravel and lodgingmerck sharp  dohme corporation united states dollarsresearchglaxosmithkline llc united states dollarsconsulting feesboehringer ingelheim pharmaceuticals inc united states dollarsconsulting feesbristolmyers squibb company united states dollarsconsulting feesbristolmyers squibb company united states dollarstravel and lodgingabbvie inc united states dollarsconsulting feesabbvie inc united states dollarsfood and beveragesabbvie inc united states dollarsfood and beveragesboehringer ingelheim pharmaceuticals inc united states dollarstravel and lodgingboehringer ingelheim pharmaceuticals inc united states dollarsfood and beveragesboehringer ingelheim pharmaceuticals inc united states dollarsfood and beveragesboehringer ingelheim pharmaceuticals inc united states dollarstravel and lodgingboehringer ingelheim pharmaceuticals inc united states dollarsfood and beveragesboehringer ingelheim pharmaceuticals inc united states dollarsconsulting feesvertex pharmaceuticals incorporated united states dollarsconsulting feesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarstravel and lodgingbristolmyers squibb company united states dollarstravel and lodgingbristolmyers squibb company united states dollarstravel and lodgingbristolmyers squibb company united states dollarstravel and lodgingbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarstravel and lodgingbristolmyers squibb company united states dollarsfood and beveragesbristolmyers squibb company united states dollarsfood and beveragesgilead sciences incincivek united states dollarsfood and beveragesvertex pharmaceuticals incorporatedvireadhbv united states dollarsfood and beveragesgilead sciences incincivek united states dollarsfood and beveragesvertex pharmaceuticals incorporatedincivek united states dollarsfood and beveragesvertex pharmaceuticals incorporatedbaraclude united states dollarsfood and beveragesbristolmyers squibb companyincivek united states dollarsfood and beveragesvertex pharmaceuticals incorporatedhepsera united states dollarstravel and lodginggilead sciences inchepsera united states dollarsfood and beveragesgilead sciences incpromacta rebozet revolade united states dollarsconsulting feesglaxosmithkline llcpromacta rebozet revolade united states dollarstravel and lodgingglaxosmithkline llcrebozet revolade promacta united states dollarstravel and lodgingglaxosmithkline llcincivek united states dollarsfood and beveragesvertex pharmaceuticals incorporated sharemore on healthgrovesubstance abuse treatment centers idanchor textshepherd hill newark ohiouwyxvrbycedar lodge guntersville alabamapacifica house hawthornebrylin substance abuse treatment centers offer services to help people overcome substance abuse healthgroves treatment facilities topic can help people find centers based on treatment methods facilities payment options and more × references sources cms db and vendor sites show details  hide details  was this page helpful yes no blkhol email welcome to hi we see you would like to submit a rating please login or create an account to do so thank you sign in with login with google login with facebook well never post without your permission dont have an account sign up now privacy terms  conditions   graphiq inc all rights reserved support terms privacy ad choices and cookie policy microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft dr nezam afdhal md  hepatologist in boston ma xcuwaasbzdsx show all results hide results show all results hide results home  doctors  massachusetts ma  boston  dr nezam afdhal dr nezam afdhal md read reviews phone number advertisement advertisement dr nezam afdhal md hepatology internal medicine  years experience read reviews phone number overview patient reviews locations  directions insurances hospital affiliations patient experience have you seen dr nezam afdhal before be the first to review write a review patient reviews advertisement similar doctors see how dr nezam afdhal compares to similar doctors below doctor dr gail kaufman gastroenterologyinternal medicine  years experience rate this doctor view profile doctor dr michael curry hepatologyinternal medicine  years experience rate this doctor view profile doctor dr mary albrecht infectious diseaseinternal medicine  years experience rate this doctor view profile detailed report find more like this advertisement locations  directions beth israel deaconess medical center  francis st boston ma  phone number get directions advertisement specialties  expertise specialties hepatology internal medicine expertise constipation hepatitis c irritable bowel syndrome ibs ulcerative colitis background languages spoken english education school royal college of surgeons in ireland   advertisement advertisement dr nezam afdhal update your information here advertisement advertisement × have you visited dr nezam afdhal share your experience click to rate submit by submitting this review i agree to the user agreement and verify that i have received treatment from this doctor i havent visited this doctor yet continue advertisement